RESEARCH INDEX

The Index contains published research studies and selected key documents and articles, listed by subject matter, on myalgic encephalomyelitis, myalgic encephalopathy, and/or chronic fatigue syndrome (ME/CFS), and Long Covid. It is searchable and will match research titles, the authors of the papers and the journals which published the paper.

To see research funded by the ME Association click here

Research Categories

The categories listed below show the number of papers in brackets which will be revealed when the category is clicked

BIOMEDICAL RESEARCH (109)

• “It's All in Your Head” – Medicine's Silent Epidemic.

  Burke M

  2019

  JAMA Network [Epub ahead of print].
• ‘Illness-related cognition, distress and adjustment in functional stroke symptoms, vascular stroke, and chronic fatigue syndrome'.

  Jones A et al

  2021

  European Journal of Health Psychology
• 2012) Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date.

  van Loenhout JAF, et al

  0

  BMC Infectious Diseases 12: 280.
• A 6-month Ibudilast treatment regimen aimed to improve brain function in ME/CFS patients: A case study

  Ziaja CP, et al.

  2023

  Journal of the Neurological Sciences 455: 122152
• A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease.

  Asad HN, et al

  2022

  CNS & Neurological Disorders Drug Targets. [Epub ahead of print.]
• A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection.

  Buchwald D et al

  1992

  Annals of Internal Medicine 116(2): 103-113.
• A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection.

  Buchwald D et al

  1992

  Annals of Internal Medicine 116(2): 103-113.
• A comparative polysomnography analysis of sleep in healthy controls and patients with chronic fatigue syndrome.

  Gotts ZM et al

  2016

  Fatigue: Biomedicine, Health & Behavior 4(2): 80-93.
• A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV-6 and HHV-7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis.

  Maltsev D

  2022

  Microbiology and Immunology 66 (4): 193-199.
• A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is there a common cause?

  Morris G et al

  2017

  Molecular Neurobiology.
• A compromised paraventriculr nucleus within a dysfunctional hypothalamus: A novel neuroinflammatory paradigm for ME/CFS.

  Mackay A and Tate WP

  2018

  International Journal of Immunopathology and Pharmacology.
• A concerning display of medical indifference: reply to ‘Chronic fatigue syndrome and an illness-focused approach to care: controversy, morality and paradox'.

  O'Leary D

  2020

  Medicine Humanities 46 (4): e4.
• A distinctive profile of family genetic risk scores in a Swedish national sample of cases of fibromyalgia, irritable bowel syndrome, and chronic fatigue syndrome compared to rheumatoid arthritis and major depression.

  Kendler K, et al

  2022

  Psychological Medicine : 1-8.
• A gene signature for post-infectious chronic fatigue syndrome.

  Gow JW, et al

  2009

  BMC Medical Genomics 2: 38.

  Funded by the ME Association
• A Machine Learning Approach to the Differentiation of Functional Magnetic Resonance Imaging Data of Chronic Fatigue Syndrome (CFS) From a Sedentary Control.

  Provenzano D et al

  2020

  Frontiers in Computer Neuroscience 14: 2.
• A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Hoel F, et al. et al

  2021

  JCI Insight 6 (16): 149217.
• A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Hoel F et al

  2021

  JCI Insight 6 (16): 149217.
• A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome

  Stussman B et al

  2023

  Med Rxiv
• A Molecular network approach reveals shared cellular and molecular signatures between chronic fatigue syndrome and other fatiguing illnesses.

  Comella PH, et al

  2021

  medRxiv [Preprint] 01.29.21250755.
• A neuro-inflammatory model can explain the onset, symptoms and flare-ups of myalgic encephalomyelitis/chronic fatigue syndrome.

  Mackay A

  2019

  Journal of Primary Health Care 11 (4): 300-307.
• A neuroinflammatory paradigm can explain Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome and Post-COVID-19 Fatigue Syndrome

  Mackay A

  2023

  University of Otago
• A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy.

  Xu J et al

  2018

  RSC, Analyst, 144 (3): 913-920.

  Funded by the ME Association
• A New Virus for Old Diseases?

  Coffin JM and Stoye JP.

  2009

  Science 326(5952): 530.
• A paradigm for chronic fatigue syndrome: caught between idiopathic intracranial hypertension and spontaneous intracranial hypotension; caused by cranial venous outflow obstruction.

  Higgins JNP and Pickard JD

  2021

  Fatigue: Biomedicine, Health & Behavior
• A population-based investigation into the prevalence of chronic fatigue syndrome in United States military Veterans with chronic pain

  Adamowicz J et al

  2023

  Fatigue: Biomedicine, health and behaviour
• A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

  Raijmakers RPH, et al

  2019

  Journal of Translational Medicine 17 (1): 157.
• A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome.

  Raijmakers RPH et al

  2019

  Journal of Translational Medicine 17 (1): 157.
• A profile of patients with postural tachycardia syndrome and their experience of healthcare in the UK.

  Kavi L et al

  2016

  The British Journal of Cardiology 23(1): 33.
• A Proposal for Explaining Progression from Light/Moderate to Severe Chronic Fatigue.

  Hock A.

  2020

  ES Journal of Nutritional Health 1 (2).
• A Proposed Explainable Artificial Intelligence-Based Machine Learning Model for Discriminative Metabolites for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Yagin FH et al

  2023

  Diagnostics 2023
• A Proposed New Model to Explain the Role of Low Dose Non-DNA Targeted Radiation Exposure in Chronic Fatigue and Immune Dysfunction Syndrome

  Cocchetto A et al

  2023

  International Journal of Molecular Sciences
• A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.

  Kedor C, et al

  2022

  Nature Communications 13: 5104.
• A prospective randomized, double-blind placebo-controlled study to evaluate the effectiveness of neuroprotective therapy using functional brain MRI in patients with post-covid chronic fatigue syndrome

  Tanashyan M et al

  2023

  Biomedicine and Pharmacotherapy
• A reboot for chronic fatigue syndrome research.

  Maxmen A

  2018

  Nature 553 (7686): 14-17.
• A relational analysis of an invisible illness: A meta-ethnography of people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and their support needs.

  Pilkington K, et al

  2020

  Social Science and Medicine 265: 113369.
• A Retrospective Outcome Study of 42 Patients with Chronic Fatigue Syndrome, 30 of Whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation.

  Kenyon J, et al

  2019

  Human Microbiome Journal 13.
• A role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?

  Navaneetharaja N, et al

  2016

  Journal of Clinical Medicine 5 (6), 55 doi: 10.3390/jcm5060055.
• A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.

  Sweetman E et al

  2020

  Journal of Translational Medicine 18 (365).
• A System Theoretic Investigation of Cortisol Dysregulation in Fibromyalgia Patients with Chronic Fatigue.

  Pednekar DD et al

  2020

  2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).
• A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).

  Corbitt M et al

  2019

  BMC Neurology 19 (207).
• A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis.

  Du Preez S et al

  2018

  Systematic Reviews 7 (1): 241.
• A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).

  Huth TK et al

  2020

  Journal of Translational Medicine 18: 198.
• A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.

  Holden S et al

  2020

  Journal of Translational Medicine 18 (1): 290.
• A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.

  Eaton-Fitch N et al

  2019

  Systematic Review 8 (279).
• A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.

  Maksound R

  2020

  PLoS One 15 (4).
• A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.

  Maksoud R et al

  2021

  Journal of Translational Medicine 19 (1): 81.
• A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

  Corbitt M, et al

  2018

  Probiotics and Antimicrobial Proteins
• A systematic review of quantitative EEG findings in Long COVID, Fibromyalgia and Chronic Fatigue Syndrome

  Silva-Passadouro B, et al.

  2023

  MedRxiv [Preprint]
• A systematic review of the association between fatigue and genetic polymorphisms.

  Wang T et al

  2017

  Brain Behaviour Immunology doi: 10.1016/j.bbi.2017.01.007.
• A systemic review and critical evaluation of the immunology of chronic fatigue syndrome.

  Lyall M et al

  2003

  Journal of Psychosomatic Research 55(2): 79-90.
• A Timely Multidisciplinary Update on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Theoharides T

  2019

  Clinical Therapeutics 41 (4): 610-611.
• A Twin Study of Chronic Fatigue.

  Buchwald D, et al

  2001

  Psychosomatic Medicine 101 (2): 103-113
• A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against 2-adrenergic receptors.

  Wirth K and Scheibenbogen C

  2020

  Autoimmune Reviews 19 (6).
• A unifying theory for cognitive abnormalities in functional neurological disorders, fibromyalgia and chronic fatigue syndrome: systematic review.

  Teodoro T et al

  2018

  Journal of Neurology, Neurosurgery and Psychiatry 98 (12): 1308-1319.
• A Validated Scale for Assessing the Severity of Acute Infectious Mononucleosis.

  Katz BZ, et al

  2019

  The Journal of Pediatrics [Epub ahead of print].
• A View Into the Mechanisms Underlying TORC1, AMPK, and Complex V Activity in Myalgic Encephalomyelitis Using the Dictyostelium discoideum Model.

  Arnold B

  2022

  Master dissertation, La Trobe University
• Aberrations in the Cross-Talks Among Redox, Nuclear Factor-κB and Wnt/Catenin Pathway Signaling Underpin Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: A Review and New Hypothesis Based on Results of Network, Enrichment and Annotation Analyses.

  Maes M et al

  2022

  Frontiers in Psychiatry 13: 822382.
• Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome.

  Bakheit AM et al

  1993

  Acta Neurologica Scandinavica 87(3): 234-238.
• Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome.

  Lien K, et al

  2019

  Physiological Reports 7 (11).
• Abnormal Impedance Cardiography Predicts Symptom Severity in Chronic Fatigue Syndrome.

  Peckerman A, et al

  2003

  The American Journal of the Medical Sciences 326(2): 55-60.
• Abnormal thermoregulatory responses in adolescents with chronic fatigue syndrome: relation to clinical symptoms.

  Wyller VB et al

  2007

  Pediatrics 120: e129-e137.
• Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome.

  Jones DEJ et al

  2010

  Journal of Internal Medicine 267(4): 394-401.
• Abnormalities in response to vasopressin infusion in chronic fatigue syndrome.

  Altemus M et al

  2001

  Psychoneuroendocrinology 26(2): 175-188.
• Abnormalities of AMPK activation and glucose uptake in cultured skeletal muscle cells from individuals with chronic fatigue syndrome.

  Brown AE et al

  2015

  PloS ONE 10(4): e0122982.
• Achieving symptom relief in patients with myalgic encephalomyelitis by targeting the neuro-immune interface and optimizing disease tolerance

  Rodriguez L et al

  2023

  Oxford open Immunology
• Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.

  Lidbury BA et al

  2017

  Journal of Translational Medicine 15: 60.
• Activity patterns in response to symptoms in patients being treated for chronic fatigue syndrome: An experience sampling methodology study.

  Brand R et al

  2017

  Health Psychology 36 (3): 264-269.
• Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Pereira G, et al

  2021

  Frontiers in Systems Neuroscience (eCollection 2021)15: 698240.
• Acute enterovirus infection followed by myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) and viral persistence.

  Chia JK, et al

  2010

  Journal of Clinical Pathology 63(2): 165-168.
• Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome.

  Komaroff A

  2019

  JAMA [Epub ahead of print].
• Aetiological Understanding of Fibromyalgia, Irritable Bowel Syndrome, Chronic Fatigue Syndrome and Classificatory Analogues: A Systematic Umbrella Review

  Kleinstäuber M, et al.

  2023

  Clinical Psychology in Europe 5 (3): e11179.
• Allergy and the chronic fatigue syndrome.

  Straus SE et al

  1988

  Journal of Allergy and Clinical Immunology 81(5): 791-795.
• Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Thapalia K et al

  2022

  Frontiers in Neuroscience 16: 848730.
• Alterations in Diurnal Salivary Cortisol Rhythm in a Population-Based Sample of Cases with Chronic Fatigue Syndrome.

  Nater UM et al

  2008

  Psychosomatic Medicine 70(3): 298-305.
• Altered Effective Connectivity of Resting-State Networks by Tai Chi Chuan in Chronic Fatigue Syndrome Patients: A Multivariate Granger Causality Study.

  Li Y et al

  2022

  Frontiers in Neurology 13: 858833.
• Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

  Blauensteiner J, et al

  2021

  Scientific Reports 11: 10604.
• Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.

  Blauensteiner J, et al

  2021

  Scientific Reports 11: 10604.
• Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Maya J et al

  2023

  International Journal of Molecular Sciences 24 (3): 2010.
• Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls.

  Bradley AS et al

  2013

  Clinical & Experimental Immunology 172(1): 73-80.
• Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review.

  Nijs J et al

  2014

  Exercise Immunology Review 20: 94-116.
• Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome

  Jammes Y et al

  2020

  Journal of Translational Medicine 18 (1): 173.
• Altered right anterior insular connectivity and loss of associated functions in adolescent chronic fatigue syndrome.

  Wortinger LA et al

  2017

  PLoS One 12 (9): e0184325.
• Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome.

  Fujii H et al

  2020

  Journal of Neuroimaging 30 (6): 822-827.
• An Adrenalectomy Mouse Model Reflecting Clinical Features for Chronic Fatigue Syndrome.

  Lee JS et al

  2020

  Biomolecules 10 (1).
• An analysis of 2‐day cardiopulmonary exercise testing to assess unexplained fatigue.

  Lindheimer J, et al

  2020

  Physiological Reports 8 (17).
• An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Wirth KL et al

  2021

  Journal of Transitional Medicine 19:471.
• An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Wirth KL et al

  2021

  Journal of Transitional Medicine 19:471.
• An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Wirth KL, et al

  2021

  Journal of Transitional Medicine 19:471.
• An international survey of experiences and attitudes towards pacing using a heart rate monitor for people with myalgic encephalomyelitis/chronic fatigue syndrome

  Clague-Baker N et al

  2023

  Work
• An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.

  Missailidis D et al

  2020

  International Journal of Molecular Science 21 (3) 1074.
• An understanding of the immune dysfunction in susceptible people who develop the post-viral fatigue syndromes Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID

  Walker MOM et al

  2023

  Medical Research Archives 11 (7.1)
• Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.

  Capdevila L, et al. et al

  2021

  Sensors (Basel Switzerland) 21 (11): 3746
• Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Li K, et al

  2021

  Diagnostics (Basel, Switzerland) 11 (3): 460.
• Anti-Correlated Myelin-Sensitive MRI Levels in Humans Consistent with a Subcortical to Sensorimotor Regulatory Process- Multi-Cohort Multi-Modal Evidence.

  Barnden L, et al. et al

  2022

  Brain Sciences 12 (12): 1693.
• Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  Blomberg J et al

  2019

  Frontiers in Immunology 10: 1946.
• Antibodies to ß adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.

  Loebel M et al

  2016

  Brain, Behavior, and Immunity 52: 32-39.
• Antinuclear antibodies in patients with chronic fatigue syndrome.

  Nishikai

  2007

  Nihon rinsho; Japanese journal of clinical medicine 65(6): 1067-1070.
• Antiviral Pathway Activation in Patients with Chronic Fatigue Syndrome and Acute Infection.

  Gow JW, et al

  2001

  Clinical Infectious Diseases 33(12): 2080-2081.

  Funded by the ME Association
• Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

  Domingo JC et al

  2021

  Antioxidants & Redox Signal 34 (18): 1420-1427.
• Are Circulating Fibroblast Growth Factor 21 and N-Terminal Prohormone of Brain Natriuretic Peptide Promising Novel Biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

  Domingo JC, et al

  2021

  Antioxidants & Redox Signal 34 (18): 1420-1427.
• Are probiotic treatments useful on fibromyalgia syndrome or chronic fatigue syndrome patients? A systematic review.

  Roman P, et al

  2018

  Beneficial Microbes 9 (4): 603-611.
• Are there sleep-specific phenotypes in patients with chronic fatigue syndrome? A cross-sectional polysomnography analysis.

  Gotts ZM et al

  2013

  BMJ Open 3(6): e002999.
• Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers. J

  Asprusten TT et al

  2021

  ournal of Translational Medicine 19 (1): 48.
• Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test.

  Tomas C et al

  2019

  Scientific Reports 9.
• Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Almenar-Perez E, et al

  2020

  Scientific Reports 10 (1): 2064.
• Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Almenar-Perez E, et al

  2020

  Scientific Reports 10 (1): 2064.

  Funded by the ME Association
• Assessing health state utilities for people with myalgic encephalomyelitis/chronic fatigue syndrome in Australia using the EQ-5D-5L, AQoL-8D and EQ-5D-5L-psychosocial instruments

  Orji N et al

  2023

  Quality of Life research
• Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS sleep and pain short forms.

  Yang M et al

  2022

  Quality of Life Research.
• Assessing sleep and pain among adults with myalgic encephalomyelitis/chronic fatigue syndrome: psychometric evaluation of the PROMIS sleep and pain short forms.

  Yang M et al

  2022

  Quality of Life Research.
• Assessment of Post-Exertional Malaise (PEM) in Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS): A Patient-Driven Survey.

  Holtzman C et al

  2019

  Diagnostics 9 (1).
• Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome.

  Ichise M et al

  1992

  Nuclear Medicine Communications 13(10): 767-772.
• Association analysis between symptomology and herpesvirus IgG antibody concentrations in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis

  Domingues TD et al

  2023

  Heliyon 9(7): e18250
• Association Between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Cardiovascular Disease

  Denu M et al

  2023

  Research Square (Preprint)
• Association between Covid-19 and Fatigue in Patients with Immune-Mediated Rheumatic Diseases in an Outpatient Service

  Neto SB,F et al.

  2023

  Journal of Clinical Rheumatology
• Association between serotonin transporter gene polymorphism and chronic fatigue syndrome.

  Narita M et al

  2003

  Biochemical and Biophysical Research Communications 311(2): 264-266.
• Association between serotonin transporter gene polymorphism and chronic fatigue syndrome.

  Narita M, et al

  2003

  Biochemical and Biophysical Research Communications 311(2): 264-266.
• Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Chapenko S et al

  2012

  Advances in Virology 2012: 205085.
• Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective cohort study

  Domingo J et al

  2023

  Research Square
• Association of T and NK Cell Phenotype with the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Rivas JL et al

  2018
• Associations between daily routines and social support among women with chronic fatigue syndrome

  Rosenberg M et al

  2023

  Scandinavian Journal of Occupational Therapy
• Associations Between Psychological and Immunological Variables in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Systematic Review.

  Raanes EFW and Stiles TC

  2021

  Frontiers in Psychiatry 12: 716320.
• Astragalus polysaccharide ameliorated complex factor-induced chronic fatigue syndrome by modulating the gut microbiota and metabolites in mice

  Xintong W et al

  2023

  Biomedicine & Pharmacotherapy
• At the Root of 3 “Long” Diseases: Persistent Antigens Inflicting Chronic Damage on the Brain and Other Organs in Gulf War Illness, Long-COVID-19, and Chronic Fatigue Syndrome.

  James LM and

  2022

  Neuroscience Insights
• Attentional Processing and Interpretative Bias in Functional Neurological Disorder.

  Keynejad R et al

  2020

  Psychosomatic Medicine 82 (6): 586-592.
• Augmentation of Anaerobic Pentose Phosphate Pathway Dysregulates Tetrahydrobiopterin Metabolism in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) Patients with Orthostatic Intolerance: A Pilot Study

  Bulbule S, et al

  2023

  ResearchSquare [Preprint]
• Autoantibodies to Beta-Adrenergic and Muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients- a validation study in plasma and cerebrospinal fluid from two Swedish cohorts.

  Bynke A et al

  2020

  Brain, Behavior & Immunity & Health 7:100107.
• Autoantibodies to Selenoprotein P in Patients with Chronic Fatigue Syndrome Suggest Selenium Transport Impairment and Acquired Resistance to Thyroid Hormone

  Sun Q et al

  2023

  SSRN
• Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Freitag H, et al

  2021

  Journal of Clinical Medicine 10 (16): 3675.
• Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Freitag H et al

  2021

  Journal of Clinical Medicine 10 (16): 3675.
• Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity.

  Ryabkova VA, et al

  2022

  Preprints 2022: 2022120224.
• Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity.

  Ryabkova VA, et al

  2022

  Preprints 2022: 2022120224.
• Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant-Related Symptoms and Post-COVID Syndrome.

  Mahroum N and Shoenfeld Y

  2022

  Pathophysiology 29 (3): 414-425.
• Autoimmune Autonomic Dysfunction Syndromes: Potential Involvement and Pathophysiology Related to Complex Regional Pain Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Silicone Breast Implant-Related Symptoms and Post-COVID Syndrome.

  Mahroum N and Shoenfeld Y

  2022

  Pathophysiology 29 (3): 414-425.
• Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants.

  Malkova AM and Shoenfeld Y

  2022

  Autoimmunity Reviews: 103230. [In press, Journal Pre-proof]
• Autoimmune autonomic nervous system imbalance and conditions: Chronic fatigue syndrome, fibromyalgia, silicone breast implants, COVID and post-COVID syndrome, sick building syndrome, post-orthostatic tachycardia syndrome, autoimmune diseases and autoimmune/inflammatory syndrome induced by adjuvants.

  Malkova AM and Shoenfeld Y

  2022

  Autoimmunity Reviews: 103230. [In press, Journal Pre-proof]
• Autoimmune Basis for Postural Tachycardia Syndrome.

  Li H et al

  2014

  Journal of the American Heart Association 3: e000755.
• Autoimmune Gene Expression Profiling of Fingerstick Whole Blood in Chronic Fatigue Syndrome.

  Wang Z, et al

  2022

  ResearchSquare [Preprint].
• Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants' (ASIA): analysis of 93 cases.

  Zafrir Y, et al

  2012

  Lupus 21(2): 146-152.
• Autoimmunity-Related Risk Variants in PTPN22 and CTLA4 Are Associated With ME/CFS With Infectious Onset.

  Steiner S, et al

  2020

  Frontiers in Immunology 11: 578.
• Autonomic markers, chronic fatigue syndrome, and post-exertion states.

  Friedberg F

  2019

  Journal of Psychosomatic Research 127.
• Autonomic nervous system function, activity patterns, and sleep after physical or cognitive challenge in people with chronic fatigue syndrome.

  Cvejic E et al

  2017

  Journal of Psychosomatic Research 103: 91-94.
• Autonomic Nervous System Functioning Related to Nocturnal Sleep in Patients with Chronic Fatigue Syndrome Compared to Tired Controls.

  Orjatsalo M et al

  2017

  Journal of Clinical Sleep Medicine.
• Autonomic Nervous System Functioning Related to Nocturnal Sleep in Patients with Chronic Fatigue Syndrome Compared to Tired Controls.

  Orjatsalo M et al

  2017

  Journal of Clinical Sleep Medicine.
• Autonomic Phenotypes in Chronic Fatigue Syndrome (CFS) Are Associated with Illness Severity: A Cluster Analysis.

  Słomko J et al

  2020

  Journal of Clinical Medicine 9 (8).
• Binocular Vision in Chronic Fatigue Syndrome.

  Godts D et al

  2016

  The American Orthoptic Journal 66 (1): 92-97.
• Biochemical Evidence for a novel low molecular weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome.

  Suhadolnik RJ, et al

  1997

  Journal of Interferon & Cytokines Research 17(7): 377: 385.
• Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.

  Fernandez-Guerra P et al

  2021

  Biomolecules 11: 961.
• Bioimpedance spectroscopy characterization of Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome (ME/CFS) peripheral blood mononuclear cells

  Martinez Rodriguez S et al

  2023

  Biomedical Letters
• Bioimpedance spectroscopy characterization of osmotic stress processes in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME-CFS) blood samples

  Fernández AO et al

  2021

  Authorea July 11
• Biological underpinnings of chronic fatigue syndrome begin to emerge.

  Maxmen A

  2017

  Nature 543 (7647): 602.
• Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review

  Makoud R et al

  2023

  BMC Medicine
• Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidyl peptidase IV/CD26.

  Fletcher MA et al

  2010

  PloS ONE 5(5): e10817.
• Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.

  Gravelsina S, et al

  2022

  Frontiers in Immunology 13: 928945.
• Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.

  Gravelsina S, et al

  2022

  Frontiers in Immunology 13: 928945.
• Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.

  Gravelsina S et al

  2022

  Frontiers in Immunology 13: 928945.
• Blood volume status in CFS/ME correlates with the presence or absence of orthostatic symptoms.

  Campen CM, et al

  2018

  Frontiers in Paediatrics [Epub ahead of print].
• Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome.

  oCiregia F et al

  2016

  Translational Psychiatry doi: 10.1038/to/2016.184.
• Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C] WAY-100635.

  Cleare AJ et al

  2005

  Biological Psychiatry 57(3): 239-246.
• Brain abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: Evaluation by diffusional kurtosis imaging and neurite orientation dispersion and density imaging,

  Kimura Y et al

  2018

  Journal of Magnetic Resonance Imaging [Epub ahead of print].
• Brain glial activation in fibromyalgia- A multi-site positron emission tomography investigation.

  Albrecht DS et al

  2018

  Brain, Behaviour and Immunity 75: 72:83.
• Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome.

  Lange G et al

  1999

  Journal of the Neurological Sciences 171(1): 3-7. Commentary on page 1-2.
• Brain MRI abnormalities exist in chronic fatigue syndrome.

  Keenan PA

  1999

  Journal of the Neurological Sciences 171(1): 1-2.
• Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.

  Tirelli U et al

  1998

  The American Journal of Medicine 105(3): 54S-58S.
• Brain Regions Involved in Fatigue Sensation: Reduced Acetylcarnitine Uptake into the Brain.

  Kuratsune H et al

  2002

  NeuroImage 17(3): 1256-1265.
• Brain Responses in CFS and TMD to Autonomic Challenges: An Exploratory fMRI Study.

  Vuong Q et al

  2019

  JDR Clinical and Translational Research [Epub ahead of print].
• Brain Science on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,

  Wantanabe Y

  2018

  Brain and Nerves 70 (11): 1193-1201.
• Brain-regional characteristics and neuroinflammation in ME/CFS patients from neuroimaging: A systematic review and meta-analysis

  Lee J, et al

  2023

  Autoimmunity Reviews 23 (2): 103484
• Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms

  Almulla A et al

  2023

  MedRxiv
• Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings.

  Nelson T et al

  2021

  Frontiers in Neurology 12: 769511.
• Brainstem perfusion is impaired in chronic fatigue syndrome.

  Costa DC et al

  1995

  QJM 88(11): 767-773.
• Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients

  Thapaliya K et al

  2023

  Frontiers in Neuroscience 17: 1125208
• Broken Connections: The Evidence for Neuroglial Failure in ME/CFS.

  Renz-Polster H & Bienzle D

  2021

  OSF Preprints.
• C-Reactive Protein Response in Patients with Post-Treatment Lyme Disease Symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Uhde M et al

  2018

  Clinical Infectious Diseases 67 (18).
• Can a Chronic BPPV With a History of Trauma be the Trigger of Symptoms in Vestibular Migraine, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Whiplash Associated Disorders (WAD)? A Retrospective Cohort Study,

  Tjell C et al

  2018

  Otology and Neurotology 40 (1): 96-102.
• Can the light of immunometabolism cut through “brain fog”?

  Hornig M

  2020

  Journal of Clinical Investigation 130 (3): 1102-1105.
• Cardiac Dimensions and Function Are Not Altered among Females with the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Iverson PO, et al

  2020

  Healthcare (Basel).
• Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Stevens S, et al

  2018

  Frontiers in Pediatrics 6: 242
• Cardiopulmonary responses to exercise in an individual with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome during long-term treatment with intravenous saline: A case study.

  Davenport T, et al

  2020

  Work 66 (2): 353-359.
• Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.

  Cook DB, et al

  2022

  PLoS ONE 17(3): e0265315.
• Cardiopulmonary, metabolic, and perceptual responses during exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Multi-site Clinical Assessment of ME/CFS (MCAM) sub-study.

  Cook DB, et al

  2022

  PLoS ONE 17(3): e0265315.
• Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses

  Nunes J et al

  2023

  Blood reviews
• Cardiovascular Autonomic Regulation, ETCO 2 and the Heart Rate Response to the Tilt Table Test in Patients with Orthostatic Intolerance.

  Wheeler C et al

  2022

  Applied Psychophysiology and Biofeedback.
• Cardiovascular characteristics of chronic fatigue syndrome.

  Bozzini S, et al

  2018

  Biomedical Reports 8 (1): 26-30.
• Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection.

  Hohberger B et al

  2021

  Frontiers in Medicine (Lausanne) 8: 754667.
• Case Report: Rapid and partially persistent, improvements of anorexia nervosa and probable myalgic encephalo-myelitis/chronic fatigue syndrome upon metreleptin treatment during two dosing episodes

  Antel J et al

  2023

  Frontiers in Psychology
• Catalytic Antibodies May Contribute to Demyelination in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Jensen M et al

  2023

  Biochemistry 2023
• CD24 Expression and B Cell Maturation Shows a Novel Link With Energy Metabolism: Potential Implications for Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome,

  Mensah FKF et al

  2018

  Frontiers in Immunology , 9.
• Cellular Bioenergetics is Impaired in patients with Chronic Fatigue Syndrome.

  Tomas C et al

  2017

  PLoS ONE 12(10).

  Funded by the ME Association
• Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Cliff J et al

  2019

  Frontiers in Immunology 10: 796.
• Central 5-HTergic hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like pathophysiology

  Lee J-S, et al.

  2024

  Journal of Translational Medicine 22 (1): 34
• Central Autonomic Network Disturbance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study. A Pilot Study.

  Zinn M et al

  2021

  NeuroRegulation 8 (2): 72-86.
• Central sensitisation in chronic fatigue syndrome and fibromyalgia; a case control study.

  Bourke JH et al

  2021

  Journal of Psychosomatic Research 150: 110624.
• Cerebral Blood Flow and Heart Rate Variability in Chronic Fatigue Syndrome: A Randomized Cross-Over Study.

  Malfliet A, et al

  2018

  Pain Physician 21 (1): E13-E24.
• Cerebral blood flow and heart rate variability predict fatigue severity in patients with chronic fatigue syndrome.

  Boissoneault J, et al

  2018

  Brain Imaging and Behaviour 13 (3): 789-797
• Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography.

  Campen CM, et al

  2020

  Clinical Neurophysiology Practise 5: 50-58.
• Cerebral Blood Flow Is Reduced in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients During Mild Orthostatic Stress Testing: An Exploratory Study at 20 Degrees of Head-Up Tilt Testing.

  Campen CM, et al

  2020

  Healthcare 8 (2): 169.
• Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Van Campen C, et al

  2021

  Clinical Neurophysiology Practice [In press, Journal pre-proof]
• Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation.

  He J et al

  2013

  NeuroImage: Clinical 2: 168-173.
• Cerebral vascular control is associated with skeletal muscle pH in chronic fatigue syndrome patients both at rest and during dynamic stimulation.

  He J et al

  2013

  NeuroImage: Clinical 2: 168-173.
• Cerebrospinal Fluid Proteome of Patients with Acute Lyme Disease.

  Angel TE, et al

  2012

  Journal of Proteome Research 11(10): 4814-4822
• Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.

  Helliwell AM, et al

  2020

  Clinical Epigenetics 12 (1): 167.
• Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome.

  Sweetman E et al

  2019

  International Journal of Immunopathology and Pharmacology.
• Characterising DSCATT: A case series of Australian patients with debilitating symptom complexes attributed to ticks.

  Schnall J, et al

  2021

  The Australian and New Zealand journal of psychiatry : 48674211043788.
• Characterising eye movement dysfunction in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome.

  Badham SP and Hutchinson CV

  2013

  Graefe's Archive of Clinical and Experimental Ophthalmology , 251 , 2769-2776.
• Characterization of Cortisol Dysregulation in Fibromyalgia and Chronic Fatigue Syndromes: A State-Space Approach.

  Pednekar DD et al

  2020

  IEEE [Epub ahead of print].
• Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  Du Preez S et al

  2021

  International Journal of Environmental Research and Public Health 18 (22): 11879.
• Characterization of natural killer cell phenotypes in chronic fatigue syndrome/myalgic encephalomyelitis.

  Huth TK, et al

  2014

  Journal of Clinical & Cellular Immunology 5: 223.
• Characterization of Post-exertional Malaise in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Stussman B et al

  2020

  Frontiers in Neurology 11: 1025.
• Characterizing Sjögren-Associated Fatigue: A Distinct Phenotype from ME/CFS

  Kim L et al

  2023

  Journal of Clinical Medicine
• Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.

  Wheatland R

  2005

  Medical Hypotheses 65(2): 287-295.
• Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.

  Danilenko OV et al

  2022

  Pathophysiology 29: 187-199.
• Chronic Fatigue Exhibits Heterogeneous Autoimmunity Characteristics Which Reflect Etiology.

  Danilenko OV, et al

  2022

  Pathophysiology 29: 187-199.
• Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural courses.

  Mfrch K et al

  2013

  BMC Gastroenterology 13:28.
• Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence.

  Naess H, et al

  2012

  BMC Gastroenterology 12: 13.
• Chronic fatigue syndrome after infectious mononucleosis in adolescents.

  Katz BZ, et al

  2009

  Pediatrics 124(1): 189-193.
• Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review.

  Natelson BH, et al

  2021

  Journal of American College of Cardiology 78 (10): 1056-1067.
• Chronic Fatigue Syndrome and chronic pain conditions – vitally protective systems gone wrong.

  Pederson M

  2019

  Scandinavian Journal of Pain [Epub ahead of print].
• Chronic Fatigue Syndrome and chronic pain conditions – vitally protective systems gone wrong.

  Pederson M

  2019

  Scandinavian Journal of Pain [Epub ahead of print].
• Chronic fatigue syndrome and epigenetics: The case for hyperbaric oxygen therapy in biomarker identification.

  Shah RJ.

  2021

  Journal of Pulmonology and Respiratory Research 5: 027-030.
• Chronic fatigue syndrome and epigenetics: The case for hyperbaric oxygen therapy in biomarker identification.

  Shah RJ.

  2021

  Journal of Pulmonology and Respiratory Research 5: 027-030.
• Chronic fatigue syndrome and impaired peripheral pulse characteristics on orthostasis – a new potential diagnostic biomarker.

  Allen J et al

  2012

  Physiological Measurement 33(2): 231-241.
• Chronic fatigue syndrome and mitochondrial dysfunction.

  Myhill S et al

  2009

  International Journal of Clinical and Experimental Medicine 2: 1-16.
• Chronic fatigue syndrome and the immune system: Where are we now?

  Mensah FKF et al

  2017

  Neurophysiology Clinic 47 (2): 131-138.
• Chronic fatigue syndrome in caregivers of children with cerebral palsy and affecting factors

  Pasin T et al

  2023

  Northern clinics of Istanbul
• Chronic Fatigue Syndrome in Patients with Deteriorated Iron Metabolism.

  Świątczak M et al

  2022

  Diagnostics 12 (9): 2057.
• Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach.

  Chia JK and Chia AY

  2008

  Journal of Clinical Pathology 61(1): 43-48.
• Chronic fatigue syndrome patients have alterations in their oral microbiome composition and function.

  Wang T, et al

  2018

  PLoS One 13 (9).
• Chronic fatigue syndrome therapies grounded in science hold promise.

  Saunders R

  2018

  Correspondence Nature 555(7696):311
• chronic fatigue syndrome, depression, sleep, age, intelligence and memory.

  Smith AP

  2022

  World Journal of Pharmaceutical and Medical Research 8 (7): 50-59.
• Chronic fatigue syndrome, depression, sleep, age, intelligence and memory.

  Smith AP

  2022

  World Journal of Pharmaceutical and Medical Research 8 (7): 50-59.
• Chronic Fatigue Syndrome, Viruses and Related Conditions in Women: The Liver Link

  Lorite-Ayán N

  2024

  Preprints: 2024011654
• Chronic Fatigue Syndrome. In:

  Sapra A and Bhandari P

  2021

  StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan.
• Chronic Fatigue Syndrome: A Disorder of Central Cholinergic Transmission.

  Chaudhuri A et al

  2011

  Journal of Chronic Fatigue Syndrome 3(1): 3-16.
• Chronic Fatigue Syndrome: A Quantum Mechanical Perspective.

  Simeoni RJ

  2022
• Chronic fatigue syndrome: Abnormally fast muscle fiber conduction in the membranes of motor units at low static force load.

  Klaver-Krol EG et al

  2021

  Clinical Neurophysiology 132 (4): 967-974.
• Chronic fatigue syndrome: neurological findings may be related to blood-brain barrier permeability.

  Bested AC, et al

  2001

  Medical Hypotheses 57(2): 231-237.
• Chronic fatigue syndrome: new evidence for a central fatigue disorder.

  Georgiades E et al

  2003

  Clinical Science 105(2): 213-218.

  Funded by the ME Association
• Chronic fatigue syndrome: progress and possibilities.

  Sandler CX and Lloyd AR

  2020

  The Medical Journal of Australia [Epub ahead of print].
• Chronic fatigue syndrome: understanding a complex illness.

  Holgate ST, et al

  2011

  Nature Reviews Neuroscience 12(9): 539-544.
• Chronic fatigue syndromes: real illnesses that people can recover from

  Alme T et al

  2023

  Scandinavian journal of Primary health care
• Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome

  Maia Chaves-Filho A et al

  2022

  Brain Research Bulletin
• Chronic Low-Grade Inflammation in Metabolic Disorders: Relevance for Behavioral Symptoms.

  Lasselin J and Capuron L

  2014

  NeuroImmuno Modulation 21(2-3): 95-101.
• Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

  Bornstein SR et al

  2021

  Molecular Psychiatry 27 (1): 34-37.
• Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?

  Bornstein SR, et al

  2021

  Molecular Psychiatry 27(1): 34-37.
• Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS),

  Rasa S, et al

  2018

  Journal of Translational Medicine 16 (1): 268.
• Chronotropic Intolerance: An Overlooked Determinant of Symptoms and Activity Limitation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

  Davenport T, et al

  2019

  Frontiers in paediatrics 7: 82.
• Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

  Cambras T et al

  2018

  PLoS One 13 (6).
• Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of COVID-19.

  McCarthy MJ

  2022

  Brain , Behavior, & Immunity & Health 20: 100412.
• Circadian skin temperature rhythm and dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the role of endothelin-1 in the vascular dysregulation.

  Cambras T, et al

  2022

  ResearchSquare [preprint].
• Circadian skin temperature rhythm and dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the role of endothelin-1 in the vascular dysregulation.

  Cambras T et al

  2022

  ResearchSquare [preprint].
• Circulating leptin levels in patients with myalgic encephalomyelitis, chronic fatigue syndrome or fibromyalgia: a systematic review protocol.

  Musker M et al

  2021

  JBI Evidence Syntheses 19 (3): 695-701.
• Circulating levels of GDF15 in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Melvin A et al

  2019

  Journal of Translational Medicine 17 (409).
• Circulating tumor necrosis factor-a and interferon-g are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue.

  Kerr JR, et al

  2001

  Journal of General Virology 82(12): 3011:3019.
• Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome.

  Lewis I et al

  2013

  Journal of Internal Medicine 273(5): 501-510.
• Clinical characteristics of patients with unexplainable hypothalamic disorder diagnosed by the corticotropin-releasing hormone challenge test: a retrospective study.

  Hataya Y, et al. et al

  2022

  BMC Endocrorine Disordorders 22: 312.
• Clinical History Segment Extraction From Chronic Fatigue Syndrome Assessments to Model Disease Trajectories.

  Priou S et al

  2020

  Studies in Health Technology and Information 270: 98-102.
• Clinical laboratory test findings in patients with chronic fatigue syndrome.

  Bates DW et al

  1995

  Archives of Internal Medicine 155(1): 97-103.
• Clinical Profile and Aspects of Differential Diagnosis in Patients with ME/CFS from Latvia.

  Krumina A et al

  2021

  Medicina 57 : 958.
• Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study.

  Kristiansen MS, et al

  2019

  Brain, Behaviour and Immunity [Epub ahead of print].
• Clinically accessible tools for documenting the impact of orthostatic intolerance on symptoms and function in ME/CFS.

  Lee J et al

  2020

  Work [Epub ahead of print].
• Clinically proven mDNA mutations are not common in those with chronic fatigue syndrome.

  Shoeman EM, et al

  2017

  BMC Medical Genetics 18 (1): 29.
• Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome.

  Schoeman EM et al

  2017

  MBC Medical Genetics 18: 29.

  Funded by the ME Association
• CNS findings in chronic fatigue syndrome and a neuropathological case report.

  Ferrero K et al

  2017

  Journal of Investigative Medicine 64 (6): 974-983.
• Cognitive Function Declines Following Orthostatic Stress in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Campen CM, et al

  2020

  Frontiers in Neuroscience 14: 688.
• Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease.

  DeLuca J et al

  1997

  Journal of Neurology, Neurosurgery & Psychiatry 62(2): 151-155.
• Cognitive impairments in chronic fatigue syndrome patients: choice reaction time, encoding of new information, response organisation and selective attention.

  Smith AP et al

  2022

  World Journal of Pharmaceutical and Medical Research 8(4): 27-36.
• Cognitive profile in functional disorders

  Roivainen E et al

  2023

  Cognitive Neuropsychiatry
• Cognitive task performance and subjective cognitive symptoms in individuals with Chronic Fatigue Syndrome or Fibromyalgia: A cross-sectional analysis of the Lifelines cohort study.

  Joustra M L et al

  2022

  Psychosomatic Medicine: 10.1097/PSY.0000000000001117. [Epub ahead of print]
• Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.

  Van Den Eede F et al

  2008

  Psychological Medicine 38(07): 963-973.
• Commonalities in the Features of Cancer and Chronic Fatigue Syndrome (CFS): Evidence for Stress-Induced Phenotype Instability?

  Rusin A et al

  2022

  International Journal of Molecular Sciences 23: 691.
• Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Bonilla H, et al

  2022

  Frontiers in Immunology 13: 841910.
• Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Bonilla H et al

  2022

  Frontiers in Immunology 13: 841910.
• Comparative Analysis of Extracellular Vesicles in Patients with Severe and Mild Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Bonilla H, et al

  2022

  Frontiers in Immunology 13: 841910.
• Comparing Idiopathic Chronic Fatigue and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in Males: Response to Two-Day Cardiopulmonary Exercise Testing Protocol.

  van Campen CM and Visser FC

  2021

  Healthcare 9 (6): 683.
• Comparison of a 20 degree and 70 degree tilt test in adolescent myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients

  van Campen C

  2023

  Frontiers in Pediatrics
• Comparison of assessment scores for fatigue between multidimensional fatigue inventory (MFI-K) and modified chalder fatigue scale (mKCFQ).

  Lim EJ and Son CG

  2022

  Journal of Translational Medicine 20 (1): 8.
• Comparison of serum acylcarnitine levels in patients with myalgic encephalomyelitis/chronic fatigue syndrome and healthy controls: a systematic review and meta-analysis

  Jinushi R

  2023

  Journal of Translational Medicine
• Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls

  Dibble JJ, et al.

  2024

  BMC Research Notes 17: 17
• Comparison of the Degree of Deconditioning in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients with and without Orthostatic Intolerance.

  van Campen CM and Visser FC

  2022

  Medical Research Archives 10 (6).
• Compelled loneliness and necessitated social isolation: “It’s like being on the other side of a mirror, just looking in”

  Wotherspoon, Natalie

  2021

  Sociology of Health and Illness
• Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Subtyping.

  Castro-Marrero J, et al

  2021

  Journal of Clinical Medicine 10 (18) :4171.
• Complement Component C1q as a Potential Diagnostic Tool for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Subtyping.

  Castro-Marrero J et al

  2021

  Journal of Clinical Medicine 10 (18): 4171.
• Complex syndromes of chronic pain, fatigue and cognitive impairment

  Shoenfeld Y et al

  2020

  Link ed to autoimmune dysautonomia and small fiber neuropathy. Clinical Immunology 214: 108384.
• Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids.

  Germain A et al

  2020

  Metabolites 10 (1): 34.
• Comprehensive profiling of the human intestinal DNA virome and prediction of disease-associated bacterial hosts in severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Hsieh S-Y et al

  2023

  medRxiv [Preprint]
• Comprehensive Update of the Current Understanding of Chronic Fatigue Syndrome.

  Noor N, et al

  2021

  Anaesthesiology and Pain Medicine 11 (3): e113629.
• Compression Stockings Improve Cardiac Output and Cerebral Blood Flow during Tilt Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients: A Randomized Crossover Trial.

  Van Campen C, et al

  2021

  Medicina 58 : 51.
• Connectivity between Salience and Default Mode Networks and subcortical nodes distinguishes between two classes of ME/CFS.

  Su J et al

  2022

  Brain Connectivity [Epub ahead of print].
• Connectivity between Salience and Default Mode Networks and subcortical nodes distinguishes between two classes of ME/CFS.

  Su J et al

  2022

  Brain Connectivity [Epub ahead of print].
• Consequences of sarcolemma fatigue on maximal muscle strength production in patients with myalgic encephalomyelitis/chronic fatigue syndrome

  Retornaz F et al

  2023

  Elsevier
• Contesting oppressive regimes of truth: A critical feminist re-examination of (bio)psychosocial hegemony in the field of myalgic encephalomyelitis / chronic fatigue syndrome

  Hunt J

  2023

  SocArXiv Open archive of the social sciences
• Convergent Genomic Studies Identify Association of GRIK2 and NPAS2 with Chronic Fatigue Syndrome.

  Smith AK, et al

  2011

  Neuropsychobiology 64(4): 183-194.
• Cortical autonomic network connectivity predicts symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  Zinn MA & Jason LA

  2021

  International Journal of Psychophysiology 170: 89-101.
• Cortical Hypoactivation During Resting EEG Suggests Central Nervous System Pathology in Patients with Chronic Fatigue Syndrome.

  Zinn MA et al

  2018

  Biological Psychology [Epub ahead of print].
• Cortisol Levels in Chronic Fatigue Syndrome and Atypical Depression Measured Using Hair and Saliva Specimens.

  Herane-Vives A et al

  2020

  Journal of Affective Disorders 267: 307-314.
• Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

  Kuvyani B et al

  2022

  Cellular and Molecular Life Science 79 (8): 412.
• Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle?

  Kuvyani B, et al

  2022

  Cellular and Molecular Life Science 79 (8): 412.
• Current knowledge about Chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME) causes summary.

  Prylińska-Jaśkowiak, Monika and Kożuchowski, Marcin

  2022

  Journal of Education, Health and Sport 12 (9): 712-719.
• Current Research Provides Insight into the Biological Basis and Diagnostic Potential for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Sweetman E, et al

  2019

  Diagnostics 9 (3).
• Current status of animal experiment report of acupuncture intervention in chronic fatigue syndrome based on ARRIVE guidelines and GSPC list

  Cui J et al

  2023

  Pub Med
• Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue.

  Broderick G et al

  2012

  Journal of Translational Medicine 3(6): 544-551.
• Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions.

  Patterson BK et al

  2022

  ResearchSquare [Preprint].
• Cytokine Hub Classification of PASC, ME-CFS and other PASC-like Conditions.

  Patterson BK, et al

  2022

  ResearchSquare [Preprint].
• Cytokine network analysis in a community-based pediatric sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Jason LA et al

  2022

  Chronic Illness [Epub ahead of print].
• Cytokine profiles in patients with Q fever fatigue syndrome.

  Rajimakers RPH et al

  2019

  Journal of Infectious Medicine [Epub ahead of print].
• Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.

  Giloteaux L et al

  2020

  Journal of Translational Medicine 18(1): 387.
• Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

  Clark LV et al

  2017

  Clinical Experimental Immunology 190 (3): 360-371.
• Cytokine signature associated with disease severity in chronic fatigue syndrome patients.

  Montoya JG et al

  2017

  Proceedings of the National Academy of Science 114 (34): E750-E7158.
• Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment.

  Roerink ME et al

  2017

  Journal of Translational Medicine 15: 267.
• Cytokines network analysis of cerebrospinal fluid in myalgic encephalomyelitis/ chronic fatigue syndrome.

  Hornig M et al

  2016

  Molecular Psychiatry 21(2): 261:269.
• Cytomegalovirus, Epstein-Barr Virus and Human Herpesvirus 6 Infections in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Shikova E , et al

  2020

  Journal of Medical Virology 92 (12): 3682-8.
• Cytotoxic lymphocyte microRNAs as prospective biomarkers for chronic fatigue syndrome/ myalgic encephalomyelitis.

  Brenu EW et al

  2012

  Journal of Affective Disorders 141(2): 261-269.
• Daily cytokines fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology.

  Stringer EA et al

  2013

  Journal of Translational Medicine 11:93.
• Dampness and mold hypersensitivity syndrome and vaccination as risk factors for chronic fatigue syndrome,

  Tuuminen T et al

  2018

  Autoimmune Reviews 18 (1): 107-108
• DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.

  Devereux-Cooke A, et al

  2022

  BMC Neurology 22:269.
• DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.

  Devereux-Cooke A, et al

  2022

  BMC Neurology 22:269.
• Decolonization of staphylococcus aureus and therapeutic test to assist the diagnosis in me/cfs, long covid, post-vaccine covid syndrome and other diseases with fatigue and/or chronic pain.

  Chang GA and Figueredo ANT

  2023

  ResearchGate [Preprint].
• Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome).

  Van Campen CM, et al

  2021

  Journal of Translational Medicine 19: 193.
• Deconstructing post-exertional malaise in myalgic encephalomyelitis/ chronic fatigue syndrome: A patient-centered, cross-sectional survey.

  Chu L et al

  2018

  PLoS One 13(6).
• Deconstructing post-exertional malaise: an exploratory analysis.

  McManimen SL, Sunquist ML and Jason LA

  2019

  Journal of Health Psychology
• Decreased Basal Ganglia Activation in Subjects with Chronic Fatigue Syndrome: Association with Symptoms of Fatigue.

  Miller AH et al

  2014

  PLoS ONE 9(5): e98156.
• Decreased Connectivity and Increased Blood Oxygenation Level Dependent Complexity in the Default Mode Network in Individuals with Chronic Fatigue Syndrome.

  Shan ZY et al

  2018

  Brain Connectivity.
• Decreased Expression of the CD57 Molecule in T Lymphocytes of Patients with Chronic Fatigue Syndrome.

  Espinosa P and Urra JM

  2019

  Molecular Neurobiology 56 (9): 6581-6585.
• Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients.

  Bertinat R, et al

  2022

  Vascular Pharmacology : 106953. [Epub ahead of print]
• Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients.

  Bertinat R, et al

  2022

  Vascular Pharmacology 143: 106953.
• Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome.

  Vermeulen RCW and Vermeulen van Eck IWG

  2014

  Journal of Translational Medicine 12: 20.
• Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population.

  Kitami T et al

  2020

  Scientific Reports 10(1):19933.
• Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome

  Walitt B, et al.

  2024

  Nature Communication 15: 907
• Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS.

  Guo C et al

  2023

  Cell Host & Microbe 31 (2):288-304.
• Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome.

  Loebel M et al

  2014

  PLoS ONE 9(1): e85387.
• Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome.

  Loebel M et al

  2014

  PLoS ONE 9(1): e85387.
• Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Szklarski M et al

  2021

  Frontiers in Immunology 12: 644548.
• Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome.

  Paul L et al

  1999

  European Journal of Neurology 6(1): 63-69.
• Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome.

  Paul L et al

  1999

  European Journal of Neurology 6(1): 63-69.
• Depression, evening salivary cortisol and inflammation in chronic fatigue syndrome: A psychoneuroendocrinological structural regression model.

  Milrad SF et al

  2017

  International Journal of Psychophysiology 131:124-130.
• Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome.

  Lombardi VC, et al

  2009

  Science 326(5952): 585-589. Article subsequently retracted: see Science, Alberts B (2011) 334: 1636-1636.
• Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study

  Gottschalk C et al

  2023

  International Journal of Molecular Sciences
• Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study

  Gottschalk C et al

  2023

  International Journal of Molecular Sciences
• Detection of herpes viruses in patients with myalgic encephalomyelitis /chronic fatigue syndrome in Belarus.

  Orlova S, et al

  2021

  Polish Journal of Applied Sciences 6 (2): 50-53,
• Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors.

  Lo SC, et al

  2010

  Proceedings of the National Academy of Sciences 107(36): 15874-15879. Article subsequently retracted: see Proceedings of the National Academy of Sciences, 2012 109(1): 346.
• Detection of Urine Metabolites in a Rat Model of Chronic Fatigue Syndrome before and after Exercise.

  Shao C et al

  2017

  Biomedical Research International 2017: 8182020.
• Developing a blood cell-based diagnostic test for myalgic encephalomyelitis/chronic fatigue syndrome using peripheral blood mononuclear cells

  Jiabao X et al

  2023

  medRxiv Preprint
• Developing and validating a brief screening scale for ME/CFS

  Jason L et al

  2023

  Fatigue: Biomedicine Health and Behavior
• Development and measurement properties of the PEM/PESE activity questionnaire (PAQ)

  Davenport T et al

  2023

  Work
• Development of a Mouse Model for Chronic Fatigue Syndrome.

  Janowski A et al

  2022

  The Journal of Pain 23 (5): 12.
• Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.

  González-Cebrián A, et al

  2022

  Frontiers in Medicine 9:842991.
• Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.

  González-Cebrián A, et al

  2022

  Frontiers in Medicine 9:842991.
• Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.

  González-Cebrián A, et al

  2022

  Frontiers in Medicine 9:842991.
• Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.

  Ostojic SM

  2021

  Nutrients 13 (2): 503.
• Diagnostic and Pharmacological Potency of Creatine in Post-Viral Fatigue Syndrome.

  Ostojic SM

  2021

  Nutrients 13 (2): 503.
• Diagnostic sensitivity of 2-day cardiopulmonary exercise testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Nelson MJ, et al

  2019

  Journal of Translational Medicine 17 (1) : 80.
• Differences in ME and CFS Symptomology in Patients with Normal and Abnormal Exercise Test Results

  McManimen SL and Jason LA.

  2017

  International Journal of Neurology and Nerotherapy 4 (1): 066.
• Differences in Metabolite-Detecting, Adrenergic, and Immune Gene Expression After Moderate Exercise in Patients with Chronic Fatigue Syndrome, Patients with Multiple Sclerosis, and Healthy Controls.

  White AT, et al

  2012

  Psychosomatic Medicine 74(1): 46-54.
• Differences in Symptoms among Black and White Patients with ME/CFS.

  Jason LA and Torres C

  2022

  Journal of Clinical Medicine 11 (22): 6708.
• Different risk factors distinguish myalgic encephalomyelitis/chronic fatigue syndrome from severe fatigue.

  Palacios N, et al

  2023

  Scientific Reports 13 (1): 2469.
• Differential Effects of Exercise on fMRI of the Midbrain Ascending Arousal Network Nuclei in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) in a Model of Postexertional Malaise (PEM).

  Baraniuk JN et al

  2022

  Brain Science 12 (1): 78.
• Differential Effects of Exercise on fMRI of the Midbrain Ascending Arousal Network Nuclei in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) in a Model of Postexertional Malaise (PEM).

  Baraniuk JN, et al

  2021

  Preprints : 2021110420.
• Differential Effects of Exercise on fMRI of the Midbrain Ascending Arousal Network Nuclei in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Gulf War Illness (GWI) in a Model of Postexertional Malaise (PEM).

  Baraniuk JN et al

  2021

  Preprints : 2021110420.
• Differential Metabolites and Metabolic Pathways Involved in Aerobic Exercise Improvement of Chronic Fatigue Symptoms in Adolescents Based on Gas Chromatography-Mass Spectrometry.

  Zhao S et al

  2022

  International Journal of Environmental Research and Public Health 19 : 2377.
• Differentiating post-polio syndrome from myalgic encephalomyelitis and chronic fatigue syndrome.

  Klebek L, et al

  2019

  Fatigue: Biomedicine, Health and Behaviour
• Diffusion tensor imaging reveals neuronal microstructural changes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Thapalia K et al

  2021

  The European Journal of Neuroscience 54 (6): 6214-6228.
• Discussion of the function of “wind medicine” in the treatment of chronic fatigue syndrome from the “spleen governs Kun” theory

  Tian X et al

  2023

  Chinese Journal of Integrated Traditional and Western Medicine on Digestion
• Disentangling pain and fatigue in chronic fatigue syndrome: a resting state connectivity study before and after cognitive behavioral therapy

  van der Schaaf ME, et al.

  2024

  Psychological Medicine: 1-14 [Epub ahead of print]
• Disruption of thymic central tolerance by infection with murine roseolovirus induces autoimmune gastritis.

  Bigley TM, et al

  2022

  Journal of Experimental Medicine 219 (3): e20211403.
• Distinct Cerebrospinal Fluid Proteomes Differentiate Post- Treatment Lyme Disease from Chronic Fatigue Syndrome.

  Schutzer SE et al

  2011

  PLoS ONE 6(2): e17287.
• Distinct plasma immune signatures in ME/CFS are present early in the course of illness.

  Hornig M et al

  2015

  Science Advances 1(1): e1400121.
• DNA Methylation and BDNF Expression Account for Symptoms and Widespread Hyperalgesia in Patients With Chronic Fatigue Syndrome and Fibromyalgia.

  Polli A, et al

  2020

  Arthritis Rheumatology [Epub ahead of print].
• DNA Methylation Changes in Blood Cells of Fibromyalgia and Chronic Fatigue Syndrome Patients

  Przybylowicz PK, et al.

  2023

  Journal of Pain Rearch 16: 4025-4036
• DNA Methylation Modifications Associated with Chronic Fatigue Syndrome.

  de Vega WC, et al

  2014

  PLoS ONE 9(8): e104757.
• DNA methylation signatures of functional somatic syndromes: Systematic review

  Fischer S et al

  2023

  Psychosomatic medicine
• Do diagnostic criteria for ME matter to patient experience with services and interventions? Key results from an online RDS survey targeting fatigue patients in Norway

  Kielland A et al

  2023

  J Health Psychology
• Does the Chronic Fatigue Syndrome Involve the Autonomic Nervous System?

  Freeman R and Komaroff AL

  1997

  The American Journal of Medicine 102(4): 357-364.
• Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?

  Newberry F, et al

  2018

  Clinical Science (London) 132 (5): 523-542
• Don't reject evidence from CFS therapies. Correspondence to ‘A Reboot for Chronic Fatigue Syndrome Research'

  Sharpe M, et al

  2018

  Nature 554 (7690): 31.
• Down-regulation of renin-aldosterone and antidiuretic hormone systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Miwa K.

  2017

  Journal of Cardiology 69 (4): 684-688.
• Dry eye symptoms and signs in United States Gulf War era veterans with myalgic encephalomyelitis/chronic fatigue syndrome

  Sanchez V et al

  2023

  Clinical and Experimental Ophthalmology
• Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Helliwell AM et al

  2022

  medRxiv [preprint].
• Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Helliwell AM, et al

  2022

  medRxiv [preprint].
• Dynamic Epigenetic Changes during a Relapse and Recovery Cycle in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Helliwell AM, et al

  2022

  medRxiv [preprint].
• Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome

  Azcue N et al

  2023

  Journal of Translational Medicine
• Dysautonomia and small fiber neuropathy in postCOVID condition and Chronic Fatigue Syndrome

  Azcue N et al

  2023

  Research Square
• Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts.

  Missailidis D et al

  2021

  International Journal of Molecular Sciences 22 (4): 2046.
• Dysregulation of extracellular vesicle protein cargo in female ME/CFS cases and sedentary controls in response to maximal exercise

  Giloteaux L et al

  2024

  Journal of Extracellular Vesicles 13 (1) :e12403.
• Dysregulation of the autonomic nervous system in ME/CFS and post-COVID syndrome: insights from 48-h heart rate variability monitoring

  Ziaja, CP et al.

  2022

  Journal of the Neurological Sciences 455: 121241
• Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Kavyani B, et al

  2023

  Molecular Neurobiology
• EBV-requisitioning physicians' guess on fatigue state 6 months after acute EBV infection.

  Asprusten T, et al

  2019

  BMJ Paediatrics Open 3 (1).
• EBV/HHV-6A dUTPases contribute to Myalgic Encephalomyelitis/Chronic-Fatigue-Syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.

  Cox BS, et al

  2022

  JCI Insight : e158193. [Epub ahead of print.]
• EBV/HHV-6A dUTPases contribute to Myalgic Encephalomyelitis/Chronic-Fatigue-Syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.

  Cox BS et al

  2022

  JCI Insight 7 (11): e158193.
• Editorial: Advances in ME/CFS Research and Clinical Care.

  Friedman K, et al

  2019

  Frontiers in Pediatrics [Epub ahead of print].
• Editorial: Current Insights Into Complex Post-infection Fatigue Syndromes With Unknown Aetiology: The Case of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Beyond.

  Westermeier F, et al

  2022

  Frontiers in Medicine
• Effect of Prolong-life-with-nine-turn-method (Yan Nian Jiu Zhuan) Qigong on fatigue and gastrointestinal function in patients with chronic fatigue syndrome: Study protocol for a randomized controlled trial
• Effect of transcutaneous electrical acupoint stimulation on learning and memory ability of chronic fatigue syndrome rats and its mechanisms

  Zhong X et al

  2023

  Zhen Ci Yan Jiu
• Effects of Post-Exertional Malaise on Markers of Arterial Stiffness in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Bond J, et al

  2021

  International Journal of Environmental Research and Public Health 18 (5): 2366.
• Effects of transcranial direct current stimulation and transcranial magnetic stimulation in patients with fibromyalgia. A systematic review.

  Conde-Antón Á et al

  2020

  Neurologia
• Effects of whole-body cryotherapy and static stretching are maintained 4 weeks after treatment in most patients with chronic fatigue syndrome

  Kujawski S et al

  2023

  Cryobiology
• Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis

  Driver C and D'Souza R

  2023

  Biomedicines
• Efficiency of comprehensive rehabilitation of chronic fatigue syndrome due to coronavirus infections COVID-19

  Adambaev Z et al

  2023

  BIO Web Conferences
• Electroacupuncture improves cognitive function by inhibiting NF-κB activity in rats with chronic fatigue syndrome.

  Feng C-W et al

  2021

  Zhen Ci Yan Jiu (Acupuncture Research) 46 (9) :775-81. [Article in Chinese.]
• Elevated ATG13 in serum of patients with ME/CFS stimulates oxidative stress response in microglial cells via activation of receptor for advanced glycation end products (RAGE).

  Gottschalk G, et al

  2022

  Molecular and Cellular Neuroscience 120: 103731.
• Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome.

  Ghali A et al

  2019

  Scientific Reports 9: 18817.
• Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study

  Tomas C, et al

  2017

  Open Heart 4 (2): e000697.
• Elevated energy production in chronic fatigue syndrome patients.

  Lawson N et al

  2016

  Journal of Nature and Science 2 (10) e221.
• Elevated Perceived Exertion in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia: A Meta-analysis.

  Barhost EE et al

  2020

  Medicine and Science in Sports and Exercise 52 (12): 2615-2627.
• Elevations of Ventricular Lactate Levels Occur in Both Chronic Fatigue Syndrome and Fibromyalgia.

  Natelson BH et al

  2017

  Fatigue 5 (1): 15-20.
• Emotional Awareness Correlated With Number of Awakenings From Polysomnography in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – A Pilot Study.

  Bileviciute-Ljungar I and Friberg D

  2020

  Frontiers in Psychiatry 11: 222.
• Emotional conflict processing in adolescent chronic fatigue syndrome: A pilot study using functional magnetic resonance imaging.

  Wortinger LA et al

  2017

  Journal of Clinical and Experimental Neuropsychology 39 (4): 355-368.
• Endogenous pain facilitation rather than inhibition differs between people with chronic fatigue syndrome, multiple sclerosis, and controls: An observational study.

  Collins SM et al

  2017

  Pain Physicians 20 (4): E489-E497.
• Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).

  Haffke M, et al

  2022

  Journal of Translational Medicine 20:138.
• Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).

  Haffke M, et al

  2022

  Journal of Translational Medicine 20:138.
• Endothelial dysfunction in ME/CFS patients.

  Sandvik MK et al

  2023

  PLoS One 18 (2): e0280942.
• Energy envelope maintenance among patients with myalgic encephalomyelitis and chronic fatigue syndrome: Implications of limited energy reserves.

  O'Conner K et al

  2017

  Chronic Illness 15 (1): 51-60.
• Enhanced sensitivity of the peripheral cholinergic vascular response in patients with chronic fatigue syndrome.

  Spence VA et al

  2000

  The American Journal of Medicine 108(9): 736-739.
• Enterovirus related metabolic myopathy: a post-viral fatigue syndrome.

  Lane RJM et al

  2003

  Journal of Neurology, Neurosurgery & Psychiatric 74(10): 1382:1386.
• Environmental, Neuro-immune, and Neuro-oxidative Stress Interactions in Chronic Fatigue Syndrome.

  Bjørklund G, et al

  2020

  Molecular Neurobiology 57 (11): 4598-4607.
• Epigenetic Components of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Uncover Potential Transposable Element Activation.

  Almenar-Perez E, et al

  2019

  Clinical Therapeutics 41 (4): 675-698.
• Epstein-barr virus and neurological diseases.

  Zhang N et al

  2021

  Frontiers in Molecular Bioscience 8: 816098.
• Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

  Ruiz-Pablos M, et al

  2021

  Frontiers in Immunology 12; 4637.
• Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Williams MV, et al

  2019

  Clinical Therapeutics 41 (5): 848;863.
• Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Williams MV et al

  2019

  Clinical Therapeutics 41 (5): 848-863.
• Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Williams MV, et al

  2019

  Clinical Therapeutics 41 (5): 848;863.
• Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.

  Kerr JR.

  2019

  Frontiers in Pediatrics [Epub ahead of print].
• Epstein-Barr virus induced gene-2 upregulation identifies a particular subtype of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis.

  Kerr JR.

  2019

  Frontiers in Pediatrics [Epub ahead of print].
• Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?

  Ruiz -Pablos M

  2023

  Journal of translational medicine
• Erratum to: Altered neuroendocrine control and association to clinical symptoms in adolescent chronic fatigue syndrome: a cross-sectional study.

  Wyller VB et al

  2017

  Journal of Translational Medicine 15: 157.
• Erythrocyte Deformability as a Potential Biomarker for Chronic Fatigue Syndrome,

  Saha AK et al

  2018

  Blood 132: 4874.
• Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome.

  Mandarano AH, et al

  2018

  Peer Journal 6: e4282.
• Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Lutz L et al

  2021

  Biomolecules 11 : 1359.
• Evaluation of viral infection as an etiology of ME/CFS: a systematic review and meta-analysis

  Hwang JH et al

  2023

  J Transl Med.
• Evidence for a heritable predisposition to Chronic Fatigue Syndrome.

  Albright F, et al

  2011

  BMC Neurology 11: 62.
• Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.

  Demitrack MA et al

  1991

  The Journal of Clinical Endocrinology & Metabolism 73(6): 1224-1234.
• Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Che X et al

  2022

  medRxiv [Preprint]:2021.06.14.21258895.
• Evidence in chronic fatigue syndrome for severity-dependent upregulation of prefrontal myelination that is independent of anxiety and depression.

  Barnden LR et al

  2015

  NMR in Biomedicine 28(3): 404-413.
• Evidence of a Novel Mitochondrial Signature in Systemic Sclerosis Patients with Chronic Fatigue Syndrome

  Eeden C et al

  2023

  International Journal of Molecular Sciences
• Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis.

  Nelson MJ, et al

  2019

  Medicine (Baltimore) 98 (43).
• Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy.

  Mueller C et al

  2019

  Brain Imaging and Behaviour [Epub ahead of print].
• Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and d-lactic acidosis: a systematic review.

  Wallis A, et al

  2017

  Journal of Translational Medicine 15:129.
• Excessive intracellular acidosis of skeletal muscle on exercise in a patient with a post-viral exhaustion/fatigue syndrome.

  Arnold DL et al

  1984

  The Lancet 323(8391): 137-1369.
• Exercise alters brain activation in Gulf War Illness and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Washington S et al

  2020

  Brain Communications 2 (2).
• Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome.

  Baraniuk JN et al

  2021

  PLoS One 16 (1): e0244116.
• Exercise-induce hyperalgesia, complement system and elastase activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – a secondary analysis of experimental comparative studies,

  Polli A et al

  2018

  Scandinavian Journal of Pain 19 (1): 183-192.
• Exercise-induce hyperalgesia, complement system and elastase activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – a secondary analysis of experimental comparative studies,

  Polli A et al

  2018

  Scandinavian Journal of Pain 19 (1): 183-192.
• Exercise-induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects.

  Baraniuk JN and Shivapurka N

  2017

  Scientific Reports 7: 15338.
• Exosome-Associated Mitochondrial DNA from Patients with ME/CFS Stimulates Human Cultured Microglia to Release IL-1β.

  Tsilioni I et al

  2022

  The European Journal Neuroscience [Epub ahead of print].
• Experiences of pain in paediatric chronic fatigue syndrome/myalgic encephalomyelitis: a single-centre qualitative study.

  Serafimova T et al

  2022

  BMJ Paediatrics Open 6: e001201.
• Exploring the central mechanism of mind-regulation electroacupuncture in treatment of chronic fatigue syndrome with anxiety and depression comorbidity based on functional magnetic resonance imaging

  Zeng, X et al.

  2023

  Zhongguo Zhen Jiu 44 (1): 3-11 [Article in Chinese]
• Exploring the Genetic Contribution to Oxidative Stress in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
• Exploring the joint potential of inflammation, immunity, and receptor-based biomarkers for evaluating ME/CFS progression

  Berkis U, et al.

  2023

  Frontiers in Immunology 14: 1294758.
• Exploring the management approaches of cytokines including viral infection and neuroinflammation for neurological disorders.

  Rahman MM, et al

  2022

  Cytokine 157: 155962.
• Exploring the neurocognitive consequences of post-exertional malaise in myalgic encephalomyelitis

  Leveau C, et al.

  2023

  Journal of the Neurological Sciences 455: 122590
• Factors Affecting the Characterization of Post-Exertional Malaise Derived from Patient Input.

  Holtzman C et al

  2020

  Journal of Health Disparities Research and Practise 13 (2).
• Facts and myths about chronic fatigue syndrome.

  Fink P et al

  2022

  Ugeskr Laeger 184 (21): V12210943. [Article in Danish]
• Fatigue and basal ganglia.

  Chaudhuri A and Behan PO

  2000

  Journal of the Neurological Sciences 179(1-2): 34-42.
• Fatigue and sarcoidosis.

  Sharma O

  1999

  European Respiratory Journal 13(4): 713-714.
• Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A critical review of the literature.

  van Eeden C, et al

  2022

  Expert Review of Clinical Immunology
• Fatigue in Epstein-Barr virus infected adolescents and healthy controls: A prospective multifactorial association study.

  Pederson M, et al

  2019

  Journal of Psychosomatic Research [Epub ahead of print].
• Fatigue in neurological disorders.

  Chaudhuri A and Behan PO

  2004

  The Lancet 363(9413): 978-988.
• Fatigue Is Associated with Altered Monitoring and Preparation of Physical Effort in Patients with Chronic Fatigue Syndrome.

  Van der Schaaf ME et al

  2018

  Biological Psychiatry Cognitive Neuroscience and Neuroimaging 3 (4): 392-404.
• Fatigue sensation following peripheral viral infection is triggered by neuroinflammation: who will answer these questions?

  Yamato M and Kataoka Y.

  2015

  Neural Regeneration Research 10(2): 203-204.
• Fatigue syndromes: a comparison of chronic “postviral” fatigue with neuromuscular and affective disorders.

  Wessely S and Powell R

  1989

  Journal of Neurology, Neurosurgery & Psychiatry 52(8): 940-948.
• Fatigue, chronic fatigue syndrome and migraine: Intersecting the lines through a cross-sectional study in patients with episodic and chronic migraine

  Kumar H et al

  2023

  Journal of Neurosciences in rural practice
• Fatigue, Sleep, and Autoimmune and Related Disorders.

  Zielinski M, et al

  2019

  Frontiers of Immunology 10: 1827.
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Nagy-Szakal D, et al

  2017

  Microbiome 5: 44.
• Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Nagy-Szakal D et al

  2017

  Microbiome 5: 44.
• Feedback on underperformance in patients with chronic fatigue syndrome: the impact on subsequent neuropsychological test performance.

  Roor JJ et al

  2018

  Applied Neuropsychology [Epub ahead of print].
• Female Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome or Idiopathic Chronic Fatigue: Comparison of Responses to a Two-Day Cardiopulmonary Exercise Testing Protocol.

  van Campen CMC and Visser FC

  2021

  Healthcare 9 (6): 682.
• Fibromyalgia and Chronic Fatigue Syndromes: A systematic review and meta-analysis of cardiorespiratory fitness and neuromuscular function compared with healthy individuals.

  Zambolin F, et al

  2022

  PLoS One 17 (10): e0276009.
• Fibromyalgia patients have reduced hippocampal volume compared with healthy controls.

  McCrae CS et al

  2015

  Journal of Pain Research 8: 47-52.
• Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment

  Sarzi-Puttini P et al

  2020

  Nature Reviews Rheumatology.
• Fighting Post-COVID and ME/CFS – development of curative therapies

  Scheibenbogen C et al

  2023

  Frontiers in Medicine
• Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) suggests involvement of both HLA class I and class II loci.

  Hajdarevic R et al

  2021

  Brain, Behaviour and Immunity 98: 101-109.
• Focus on Post-Exertional Malaise when approaching ME/CFS in specialist healthcare improves satisfaction and reduces deteriorations

  Wormgooer M, Rodenburg S

  2023

  Frontiers in Neurology
• Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.

  Kerr JR, et al

  1996

  Journal of General Virology 82(12): 3011-3019.
• Free-water-corrected diffusion and adrenergic/muscarinic antibodies in myalgic encephalomyelitis/chronic fatigue syndrome

  J Neuroimaging

  2023

  Kimura Y
• From Function to Physiology and Back in Adults with Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome

  Davenport TE

  2024

  PhD Thesis [University of Portsmouth]
• From IBS to ME – The dysbiotic march hypothesis.

  Berstad A, et al

  2020

  Medical Hypothesis 140, 109648.
• From Viral Infection to Autoimmune Reaction: Exploring the Link between Human Herpesvirus 6 and Autoimmune Diseases

  Sokolovska L, et al.

  2024

  Microorganisms 12 (2): 362
• Frontiers in chronic fatigue syndrome research: An analysis of the top 100 most influential articles in the field
• Functional and Morphological Differences of Muscle Mitochondria in Chronic Fatigue Syndrome and Post-COVID Syndrome

  Bizjak DA, et al.

  2024

  International Jounral of Molecular Science 25: 1675
• Functional Characterization of Muscle Fibers from Patients with Chronic Fatigue Syndrome: Case-Control Study.

  Pietrangelo T et al

  2009

  International Journal of Immunopathology and Pharmacology 22(2): 247-436.
• Functional Somatic Syndromes Are Associated With Varied Postoperative Outcomes and Increased Opioid Use After Spine Surgery: A Systematic Review

  Massod R et al

  2023

  Global spine journal
• Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome.

  Steinsvik EK, et al

  2023

  Scandinavian Journal of Gastroenterology [Epub ahead of print].
• Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.

  Light AR, et al

  2012

  Journal of Internal Medicine 271(1): 64-81.
• Gene Expression Correlates of Postinfective Fatigue Syndrome after Infectious Mononucleosis.

  Cameron B, et al

  2007

  Journal of Infectious Diseases 196(1): 56-66.
• Gene Expression Correlates of Postinfective Fatigue Syndrome after Infectious Mononucleosis.

  Cameron B, et al

  2007

  Journal of Infectious Diseases 196(1): 56-66.
• Gene expression correlates of unexplained fatigue.

  Whistler T, et al

  2006

  Pharmacogenomics 7(3): 395-405.
• Gene expression factor analysis to differentiate pathways Link ed to fibromyalgia, chronic fatigue syndrome, and depression in a diverse patient sample.

  Jacob E, et al

  2016

  Arthritis Care Research 68 (1): 132 - 140.
• Gene expression profiling in the chronic fatigue syndrome [Letter to the editor].

  Gräns H, et al

  2005

  Journal of Internal Medicine 258(4): 388-390.
• Gene Expression Subtypes in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.

  Kerr JR, et al

  2008

  Journal of Infectious Diseases 197(8): 1171-1184.
• Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia.

  Polli A, et al

  2022

  Journal of Translational Medicine 20: 487.
• Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci.

  Hajdarevic R, et al

  2022

  Brain Behavior, and Immunity 102: 362-369.
• Genetic association study in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) identifies several potential risk loci.

  Hajdarevic R, et al

  2022

  Brain Behavior, and Immunity 102: 362-369.
• Genetic associations of fatigue and other symptom domains of the acute sickness response to infection.

  Piraino B, et al

  2012

  Brain, Behavior, and Immunity 26(4): 552-558.
• Genetic evaluation of the serotonergic system in chronic fatigue syndrome.

  Smith AK et al

  2008

  Psychoneuroendocrinology 33(2): 188-197.
• Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study.

  Perez M, et al

  2019

  Frontiers in Pediatrics 7: 206.
• Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis.

  Das S, et al

  2022

  medRxiv [preprint].
• Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis.

  Das S et al

  2022

  medRxiv [preprint].
• Genetic Risk Factors for ME/CFS Identified using Combinatorial Analysis.

  Das S, et al

  2022

  medRxiv [preprint].
• Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

  Taylor K et al

  2022

  Journal of Translational Medicine
• Genetic Risk Factors of ME/CFS: A Critical Review.

  Dibble J, et al

  2020

  Human Molecular Genetics [Epub ahead of print]
• Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review.

  Tziastoudi M, et al

  2022

  Annals of Clinicial and Translational Neurology.
• Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Herrera S, et al

  2018

  Epigenetics 5: 1-17.
• Giardia-specific cellular immune responses in post-giardiasis chronic fatigue syndrome.

  Hanevik K, et al

  2017

  BMC Immunology doi: 10.1186/s12865-017-0190-3.
• Ginsenoside Rg1 can reverse fatigue behavior in CFS rats by regulating EGFR and affecting Taurine and Mannose 6-phosphate metabolism

  Chaofang L et l

  2023

  Frontiers in Pharmacology
• Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome,

  Noda M et al

  2018

  Frontiers in Psychiatry 9
• Glial Activation and Expression of the Serotonin Transporter in Chronic Fatigue Syndrome,

  Noda M et al

  2018

  Frontiers in Psychiatry 9
• Glucocorticoid receptor DNA methylation and childhood trauma in chronic fatigue syndrome patients.

  Vangeel EB et al

  2018

  Journal of Psychosomatic Research 104: 55-60.
• Gravity-induced exercise intervention in an individual with chronic fatigue syndrome/myalgic encephalomyelitis and postural tachycardia syndrome: a case report.

  Ballantine R et al

  2019

  International Journal of Therapy and Rehabilitation 26 (5).
• Gray matter volume reduction in the chronic fatigue syndrome.

  de Lange FP et al

  2005

  NeuroImage 26(3): 777-781.
• Grey and white matter differences in Chronic Fatigue Syndrome – A voxel-based morphometry study.

  Finkelmeyer A et al

  2017

  Neuroimage Clinical 17: 24-30.
• Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome.

  Roerink ME et al

  2018

  Hormones and Behaviour [Epub ahead of Print].
• Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis

  Maeda K et al

  2023

  Psychology, Health and Medicine
• Heart Rate Thresholds to Limit Activity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients (Pacing): Comparison of Heart Rate Formulae and Measurements of the Heart Rate at the Lactic Acidosis Threshold during Cardiopulmonary Exercise Testing.

  van Campen CL, et al

  2020

  Advances in Physical Education 10 (2).
• Heart rate variability in patients with somatic symptom disorders and functional somatic syndromes: A systematic review and meta-analysis.

  Ying-Chih C, et al

  2020

  Neuroscience and Biobehavioural Reviews [Epub ahead of print].
• Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients.

  Lee J, et al

  2020

  Journal of Translational Medicine 18 (1): 314.
• Herpesvirus Infection as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Nunes JM et al.

  2024

  Preprints 2024: 2024011486
• Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.

  Domingues TD, et al

  2021

  Frontiers in Medicine (Lausanne) 8: 686736.
• Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.

  Domingues TD, et al

  2021

  Frontiers in Medicine (Lausanne) 8: 686736.
• Herpesviruses Serology Distinguishes Different Subgroups of Patients From the United Kingdom Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Biobank.

  Domingues TD et al

  2021

  Frontiers in Medicine (Lausanne) 8: 686736.
• Heterogeneity in chronic fatigue syndrome – empirically defined subgroups from the PACE trial.

  Williams TE et al

  2017

  Psychological Medicine 47 (8): 1454-1465.
• Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome.

  Badawy AAB et al

  2005

  Journal of Psychopharmacology 19(4): 385-391.
• Heterogenous circulating miRNA changes in ME/CFS converge on a unified cluster of target genes: A computational analysis

  Kaczmarek, MP

  2023

  PLoS ONE 1 8(12): e0296060
• High Prevalence of Perineural Cysts in Patients with Fibromyalgia and Chronic Fatigue Syndrome.

  Hulens M et al

  2021

  Pain Medicine 22 (4): 883-890.
• Higher Prevalence of “Low T3 Syndrome” in Patients with Chronic Fatigue Syndrome: A Case-Control Study.

  Ruiz-Núñez B et al

  2018

  Frontiers in Endocrinology.
• History of Researches on ME/CFS. (Article in Japanese)

  Watanabe Y

  2018

  Brain and Nerves 70 (1): 5-9.
• Home-based testing protocol to measure physiological responses to everyday activities in ME: a feasibility study

  Clague-Baker et al

  2023

  Fatigue: Biomedicine, Health & Behavior

  Funded by the ME Association
• Homeostatic disturbance of thermoregulatory functions in rats with chronic fatigue.

  Li D et al

  2020

  Neuroscience Research [Epub ahead of print].
• Hope, disappointment, and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.

  Lacerda EM et al

  2019

  Health Expectations 22 (3): 373-384.
• How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS.

  Nacul L, et al

  2020

  Frontiers in Neurology [Epub ahead of print].
• How mycobacterium tuberculosis infection could lead to the increasing risks of chronic fatigue syndrome and the potential immunological effects: a population-based retrospective cohort study.

  Yang TY, et al

  2022

  Journal of Translational Medicine 20: 99.
• How peptic ulcer disease could potentially lead to the lifelong, debilitating effects of chronic fatigue syndrome: an insight.

  Kuo CF et al

  2021

  Scientific Reports 11 (1): 7520.
• Human Endogenous Retrovirus- K18 Superantigen Expression and Human Herpesvirus-6 and Human Herpesvirus-7 Viral Loads in Chronic Fatigue Patients.

  Oakes B, et al

  2013

  Clinical Infectious Diseases 56(10): 1394-1400.
• Human herpesvirus 6 infection and risk of Chronic fatigue syndrome: a systematic review and meta-analysis.

  Mozhgani S-H, et al

  2021

  Intervirology 65 (1): 49-57.
• Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Schreiner P, et al

  2020

  ImmunoHorizons 4 (4): 201-215.
• Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Schreiner P et al. et al

  2020

  Immunohorizons 4 (4): 201-215.
• Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Schreiner P et al

  2020

  ImmunoHorizons 4 (4): 201-215.
• Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Lande A et al

  2020

  Scientific Reports 10: 5267.
• Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray Differentiates Cases from Controls with High Specificity and Sensitivity.

  Singh S et al

  2018

  Molecular Neurobiology 55 (1): 633-641.
• Hyperactivation of proprioceptors induces microglia-mediated long-lasting pain in a rat model of chronic fatigue syndrome.

  Yasui M et al

  2019

  Journal of Neuroinflammation 16: 67.
• Hyperbaric Oxygen Therapy Counters Oxidative Stress/Inflammation-Driven Symptoms in Long COVID-19 Patients: Preliminary Outcomes

  Mrakic-Sposta S et al

  2023

  Metabolites 2023
• Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome.

  Barnden LR et al

  2018

  NeuroImage: Clinical 20; 102-109.
• Hypothalamic-Pituitary autoimmunity and related impairment of hormone secretions in chronic fatigue syndrome.

  De Ballis et al

  2021

  Journal of Clinical Endocrinology and Metabolism 106 (12): e5147-e5155.
• Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.

  Papadopoulos AS and Cleare AJ

  2012

  Nature Reviews Endocrinology 8(1): 22-32.
• Hypothalamic-Pituitary-Adrenal Axis Function in Chronic Fatigue Syndrome.

  Van Den Eede F et al

  2007

  Neuropsychobiology 55(2): 112-120.
• Hypothalamus volumes in adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): impact of self-reported fatigue and illness duration

  Byrne H et al

  2021

  Brain structure Function
• Hypothalamus volumes in adolescent Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact of self-reported fatigue and illness duration

  Byrne H

  2023

  Med Rxiv
• Hypothesis: Astrocyte dysregulation of sympathetic nervous system causes metabolic dysfunction in subset of Long COVID and ME/CFS patients

  Carnac T

  2023

  Patient-Generated Hypotheses Journal for Long COVID & Associated Conditions 1: 36-43
• Hypothesis: Chronic fatigue syndrome is caused by dysregulation of hydrogen sulfide metabolism.

  Lemle MD.

  2009

  Medical Hypotheses 72(1): 108-109.
• Hypothesis: Increasing serum soluble CD40 ligand (sCD40L) may be a biomarker of ME/CFS and chronic Long COVID progression

  Iyer V

  2023

  Patient-Generated Hypotheses Journal for Long COVID & Associated Conditions 1: 44-48
• Hypothesis: Symptomatic myodesopsia/vitreous floaters may constitute a risk factor for Long COVID and ME/CFS

  Mazewski M

  2023

  Patient-Generated Hypotheses Journal for Long COVID & Associated Conditions1: 13-20
• Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series

  Gill A, et al.

  2021

  Brain, Behavior, & Immunity - Health: 100720
• Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.

  Trivedi M, et al

  2018

  PLoS One 13 (7): e0201066.
• Identification of transient receptor potential elastatin 3 proteotypic peptides employing an efficient membrane protein extraction method for natural killer cells.

  Magawa CT et al

  2022

  Frontiers in Physiolology 13:947723.
• Identifying disrupted biological factors and patient-tailored interventions for chronic fatigue in adolescents and young adults with Q-Fever Fatigue Syndrome, Chronic Fatigue Syndrome and Juvenile Idiopathic Arthritis (QFS-study): study protocol for a randomized controlled trial with single-subject experimental case series design.

  Vroegindeweij A et al

  2022

  Trials 23: 683.
• IgG Antibody Responses to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Their Effective Potential for Disease Diagnosis and Pathological Antigenic Mimicry

  Fonseca A, et al

  2024

  Medicina 60 (1): 161
• IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS.

  Hartwig J et al

  2020

  Brain, Behaviour and Immunity & Health 3:100047.
• Illness progression in chronic fatigue syndrome: a shifting immune baseline.

  Russell L et al

  2016

  BMC Immunology 17(1): 1-11.
• Immune cell exhaustion, dysfunction, and metabolism in myalgic encephalomyelitis/chronic fatigue syndrome

  Maya J

  2024

  PhD thesis [Cornell University]
• Immune cell proteomes of Long COVID patients have functional changes similar to those in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Peppercorn K et al

  2023

  Scientific Reports 13: 22068
• Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations.

  Hornig M et al

  2017

  Translational Psychiatry 7(4): e1080.
• Immunoadsorption to remove B2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.

  Scheibenbogen C et al

  2018

  PLoS One 13 (3): e0193672.
• Immunogenetic studies in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS).

  Hajdarevic R

  2022

  Doctoral dissertation, University of Oslo
• Immunogenetic studies in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS).

  Hajdarevic R

  2022

  Doctoral dissertation, University of Oslo]
• Immunological aspects of chronic fatigue syndrome.

  Lorusso L et al

  2009

  Autoimmunity Reviews 8(4): 287-291.
• Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Rohrhofer J, et l.

  2024

  Journal of Clinical Medicine 13 (1): 275
• Immunopathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Yamamura T et al

  2018

  Brain and Nerves 70 (1): 35-40.
• Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome.

  Hanevik K, et al

  2012

  BMJ Infectious Diseases 12:258.
• Immunosignature Analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS),

  Gunther OP et al

  2018

  Molecular Neurobiology 56 (6): 4249-4257.
• Impact of Life Stressors on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Symptoms: An Australian Longitudinal Study.

  Balinas C et al

  2021

  International Journal of Environmental Resources and Public Health 18 (20): 10614.
• Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.

  Gómez-Mora E et al

  2020

  Frontiers in Immunology 11: 582330.
• Impact of pre-existing chronic viral infection and reactivation on the development of long COVID.

  Peluso MJ et al

  2022

  Journal of Clinical Investigation : e163669. [Epub ahead of print]
• Impact of Rantes from jawbone on Chronic Fatigue Syndrome.

  Lechner J et al

  2017

  Journal of Biological Regulators and Homeostatic Agents 31 (2): 321-327.
• Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.

  Langelaan M et al

  2007

  Ophthalmic Epidemiology 14 (3): 119-26.
• Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.

  Nguyen T et al

  2016

  Clinical and Experimental Immunology 187 (2): 284-293.
• Impaired cardiac function in chronic fatigue syndrome measured using magnetic resonance cardiac tagging.

  Hollingsworth KG, et al

  2012

  Journal of Internal Medicine 271(3): 264-270.
• Impaired cardiovascular response to standing in Chronic Fatigue Syndrome.

  Hollingsworth et al

  2010

  European Journal of Clinical Investigation 40(7): 608-615.
• Impaired oxygen delivery to muscle in chronic fatigue syndrome.

  McCully KK and Natelson

  1999

  Clinical Science 97(5): 603-608.
• Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Eaton-Fitch N et al

  2022

  Journal of Translational Medicine 20: 94.
• Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Eaton-Fitch N et al

  2022

  Journal of Translational Medicine 20: 94.
• Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis.

  Rowe PC et al

  2018

  Journal of Translational Medicine 16 (1): 21.
• In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity.

  Maes M et al

  2022

  CNS & Neurological Disorders - Drug Targets 21.
• In severe first episode major depressive disorder, psychosomatic, chronic fatigue syndrome, and fibromyalgia symptoms are driven by immune activation and increased immune-associated neurotoxicity

  Maes M et al

  2023

  ResearchGate
• In vitro B cell experiments explore the role of CD24, CD38 and energy metabolism in ME/CFS

  Armstrong C, et al

  2023

  Frontiers in Immunology 14: 1178882
• In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling.

  Germain A, et al

  2021

  Proteomes 9 (1): 6.
• In-Depth Analysis of the Plasma Proteome in ME/CFS Exposes Disrupted Ephrin-Eph and Immune System Signaling.

  Germain A et al

  2021

  Proteomes 9 (1): 6.
• Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID

  Liu Z et al

  2023

  medRxiv [Preprint]
• Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: implications for disease-related biomarker discovery

  Martin F et al

  2023

  Frontiers in Immunology
• Increased neutrophil apoptosis in chronic fatigue syndrome.

  Kennedy G et al

  2004

  Journal of Clinical Pathology 57(8): 891-893.
• Increased neutrophil apoptosis in chronic fatigue syndrome.

  Kennedy G et al

  2004

  Journal of Clinical Pathology 57 (8): 891-893.
• Increased Resting Energy Expenditure in the Chronic Fatigue Syndrome.

  Watson WS et al

  1998

  Journal of Chronic Fatigue Syndrome 4(4): 3-14.
• Increased risk of chronic fatigue syndrome following burn injuries.

  Tsai SY et al

  2018

  Journal of Translational Medicine 16 (1): 342.
• Increased risk of chronic fatigue syndrome following psoriasis: a nationwide population-based cohort study.

  Tsai SY et al

  2019

  Journal of Translational Medicine 17 (1): 154.
• Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

  Murrough JW et al

  2010

  NMR Biomed 23 (6): 643-650.
• Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

  Shungu DC et al

  2012

  NMR in Biomedicine 25(9): 1073-1087.
• Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles.

  Yamano E et al

  2016

  Science Reports doi: 10.1038/srep34990.
• Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.

  Monzón-Nomdedeu MB et al

  2021

  World Journal of Stem Cells 13 (8): 1134-1150.
• Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome.

  Monzón-Nomdedeu MB, et al

  2021

  World Journal of Stem Cells 13 (8): 1134-1150.
• Infectious Mononucleosis: An Updated Review

  Leung A et al

  2023

  Current Pediatric Reviews
• Inflammation correlates with symptoms in chronic fatigue syndrome.

  Komaroff AL.

  2017

  Proceedings of the National Academy of Science USA 114 (34): 8914-8916.
• Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?

  Sun Y, et al

  2022

  Frontiers in Aging Neuroscience 14: 903455.
• Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation?

  Sun Y et al

  2022

  Frontiers in Aging Neuroscience 14: 903455.
• Inflammatory proteins are altered in chronic fatigue syndrome – a systematic review and meta-analysis.

  Strawbridge R et al

  2019

  Neuroscience and Biobehavioural Reviews 107:69-83.
• Influence of Chronic Fatigue Syndrome Codiagnosis on the Relationship between Perceived and Objective Psychoneuro-Immunoendocrine Disorders in Women with Fibromyalgia

  Otero E et al

  2023

  Biomedicines
• Influence of end-tidal CO2 on cerebral blood flow during orthostatic stress in controls and adults with myalgic encephalomyelitis/chronic fatigue syndrome

  Van Campen C L et al

  2023

  Physiol Rep
• Informatics Inference of Exercise-Induced Modulation of Brain Pathways Based on Cerebrospinal Fluid Micro-RNAs in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Narayan et al

  2020

  Networks and System Medicine 3 (1): 142-158.
• Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Joseph P, et al

  2021

  Chest S0012-3692 (21) 00256-7.
• Insights into Metabolite Diagnostic Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Yamano E et al

  2021

  International Journal of Molecular Science 22 (7): 3423.
• Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.

  Nagy-Szaki D et al

  2018

  Scientific Reports 8 (1): 10056.
• Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.

  Nagy-Szaki D et al

  2018

  Scientific Reports 8 (1): 10056.
• Integrated ‘omics analysis for the gut microbiota response to moxibustion in a rat model of chronic fatigue syndrome

  Li C et al

  2023

  Journal of Traditional Chinese medicine
• Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome.

  de Vega WC, et al

  2018

  Epigenomics [Epub ahead of print].
• Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome.

  Whistler T et al

  2003

  Journal of Translational Medicine 1: 10.
• Interdisciplinary multimodal pain therapy in postviral syndromes and ME/CFS : Features, pitfalls and model concept

  Luchting B et al

  2023

  Schmerz
• Intermittent and graded exercise effects on NK cell degranulation markers LAMP‐1/LAMP‐2 and CD8 CD38 + in chronic fatigue syndrome/myalgic encephalomyelitis.

  Broadbent S and Coutts R.

  2017

  Physiological Reports 5 (5): e13091.
• Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue

  El-Salhy M

  2023

  Neurogastroenterol Motil
• Intra brainstem connectivity is impaired in chronic fatigue syndrome.

  Barnden LR et al

  2019

  Neuroimage: Clinical 24.
• Intracranial compliance is associated with symptoms of orthostatic intolerance in chronic fatigue syndrome.

  Finkelmeyer A et al

  2018

  PLoS One 13 (7): e0200068.
• Intrinsic Functional Hypoconnectivity in Core Neurocognitive Networks Suggests Central Nervous System Pathology in Patients with Myalgic Encephalomyelitis: A Pilot Study.

  Zinn ML et al

  2016

  Appl Psychophysiol Biofeedback 41: 283.
• Investigating antibody reactivity to the intestinal microbiome in severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

  Seton K et al

  2023

  Med Rxiv
• Investigating Immune Reactivity to the Intestinal Microbiome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Seaton K

  2022

  Doctoral dissertation, University of East Anglia
• Investigating Immune Reactivity to the Intestinal Microbiome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Seaton K

  2022

  Doctoral dissertation, University of East Anglia
• Investigating the Effect of COVID-19 Infection on Professional Athletes’ Post-infection With a Focus on Fatigue and Chronic Fatigue Syndrome

  Sarwary R

  2023

  SSRN
• Investigating The Enterovirus Theory Of Disease Etiology In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  O'Neal AJ

  2022

  Doctoral dissertation, Cornell University
• Investigating the factors associated with meaningful improvement on the SF-36-PFS and exploring the appropriateness of this measure for young people with ME/CFS accessing an NHS specialist service: a prospective cohort study

  Gaunt D et al

  2023

  PubMed
• Investigating the Genetic and Immunological Aetiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Dibble J

  2022

  Doctoral Dissertation, University of Edinburgh]
• Investigating the Genetic and Immunological Aetiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Dibble J

  2022

  Doctoral Dissertation, University of Edinburgh]
• Investigating the Human Intestinal DNA Virome and Predicting Disease-Associated Virus-Host Interactions in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Hsieh S-Y, et al.

  2023

  International Journal of Molecular Sciences 24 (24): 17267
• Investigating the neural substrates of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a structural and functional MRI study.

  Almutairi BS

  2022

  Doctoral dissertation, University of Bristol
• Investigating the potential role of circulatory extracellular vesicles in myalgic encephalomyelitis/ chronic fatigue syndrome

  Yran E

  2023

  Master Thesis [University of Oslo]
• Investigating the role of TGF-B and fatigue in Chronic Fatigue Syndrome.

  Dibnah B et al

  2019

  Annals of the Rheumatic Diseases 78 (2).
• Investigation into the Plasma Proteome Signature in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Squires J et al

  2023

  European Respiratory Journal
• Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis participants using the novel application of autoMACS magnetic separation and flow cytometry.

  Balinas C et al

  2017

  Asian Pacific Journal of allergy and Immunology.
• Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study.

  Wensaas KA, et al

  2012

  Gut 61(2): 214-219.
• Is chronic fatigue syndrome (CFS/ME) heritable in children, and if so, why does it matter?

  Crawley E and Davey Smith

  2007

  Archives of Disease in Childhood 92 (12): 1058-1061.
• Is reduced heart rate variability associated with functional somatic disorders? A cross-sectional population-based study; DanFunD

  Jørgensen T, et al.

  2024

  BMJ Open 14 (2): e073909.
• Isolation of ultrasmall (filterable) bacteria from patients suffering from ME, and patients and staff of a paediatric hospital

  Alharbi S

  2020

  Saudi Journal of Biological Sciences 27 (6):1566-1568.
• Joint Flexibility and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After Mononucleosis

  Poomkudy JT, et al.

  2024

  Clinical therapeutics: S0149-2918(24)00006-7 [Epub ahead of print]
• Kynurenine metabolites and ratios differ between Chronic Fatigue Syndrome, Fibromyalgia, and healthy controls.

  Groven N et al

  2021

  Psychneuroendocrinology 131: 105287.
• Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue.

  Fevang B, et al

  2022

  Frontiers in Immunology 12: 715102.
• Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue.

  Fevang B et al

  2021

  Frontier in Immunology 12: 715102.
• Latent class analysis of a heterogeneous international sample of patients with myalgic encephalomyelitis/chronic fatigue syndrome.

  Huber K et al

  2018

  Fatigue: Biomedicine, Health and Behaviour 6 (3).
• LC, POTS, and ME/CFS: Lifting the Fog

  Chambers, P

  2023

  Preprints
• Legitimizing myalgic encephalomyelitis/chronic fatigue syndrome: indications of change over a decade.

  Friedberg F

  2020

  Fatigue: Biomedicine, Health and Behaviour [Epub ahead of print].
• Lessons from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome for Long COVID Part 2: Physiological Characteristics During Acute Exercise Are Abnormal in People With Postexertional Symptom Exacerbation.

  Davenport TE et al

  2022

  JOSPT
• Lessons from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome for Long COVID Part 3: “Energy System First Aid” for People With Postexertional Symptom Exacerbation.

  Davenport TE et al

  2022

  JOSPT
• Lessons from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome for Long COVID: Postexertional Symptom Exacerbation is an Abnormal Response to Exercise/Activity.

  Davenport TE et al

  2022

  JOSPT
• Letter: Could endothelial dysfunction and vascular damage contribute to pain, inflammation and post-exertional malaise in individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)?.

  Lubell J

  2022

  Journal of Translational Medicine 20:40.
• Letter: Could endothelial dysfunction and vascular damage contribute to pain, inflammation and post-exertional malaise in individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)?.

  Lubell J

  2022

  Journal of Translational Medicine 20:40.
• Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

  Morris M et al

  2019

  Clinical Therapeutics 41 (4): 656-674.
• Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome.

  Morris M et al

  2019

  Clinical Therapeutics 41 (4): 656-674.
• Life changing response to successive surgical interventions on cranial venous outflow: A case report on chronic fatigue syndrome

  Higgins J et al

  2023

  Frontiers
• Limbic Perfusion Is Reduced in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Li X et al

  2021

  Tomography 7 (4): 675-687.
• Links between Serotonin Levels and Stress: Cortisol, Candida A./Mycetes, Omega 3/6 Ratio and Dysbiosis (Skatole/Indoxyl Sulfate) Role in Chronic Fatigue Syndrome (CFS) and Depression

  Orlandoni D et al

  2023

  Preprints
• Lipid metabolism and functional somatic disorders in the general population. The DanFunD study

  Jørgensen T, et al.

  2024

  PLoS ONE 19 (1): e0296799
• Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of unexplained severe fatigue

  Oakley J et al

  2023

  Journal of Translational Medicine
• Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS.

  Morrow AK et al

  2022

  Current Paediatric Reports
• Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort

  Legler F et al

  2023

  e clinical medicine
• Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/ myalgic encephalomyelitis.

  Brenu EW et al

  2012

  Journal of Translational Medicine 10: 88.
• Longterm course of neuropsychological symptoms and ME/CFS after SARS-CoV-2-infection: a prospective registry study

  Reuken P A et al

  2023

  PubMed
• Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: case-control study.

  Jones DEJ et al

  2012

  European Journal of Clinical Investigation 42(2): 186-194.

  Funded by the ME Association
• Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders.

  Annesley SJ and Fisher PR

  2021

  International Journal of Molecular Science 22 (9): 4536.
• Machine Learning Detects Pattern of Differences in Functional Magnetic Resonance Imaging (fMRI) Data between Chronic Fatigue Syndrome (CFS) and Gulf War Illness (GWI).

  Provenzano D et al

  2020

  Brain Sciences 10 (7).
• Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging features.

  Sebaiti M et al

  2019

  Best Practise and Research Clinical Rheumatology [Epub ahead of print].
• Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging features.

  Sebaiti M et al

  2019

  Best Practise and Research Clinical Rheumatology [Epub ahead of print].
• Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature review.

  Van Cauwenbergh D et al

  2014

  European Journal of Clinical Investigatio n 44(5): 516-526.
• Management of Post-Viral Postural Orthostatic Tachycardia Syndrome With Craniosacral Therapy

  Tafler L

  2023

  Cureus
• Managing fatigue in postural tachycardia syndrome (PoTS): The Newcastle approach.

  Strassheim V et al

  2018

  Autonomic Neuroscience 215: 56-61.
• mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.

  Mathur R, et al

  2021

  Journal of Translational Medicine 19 (1): 461.
• mapMECFS: a portal to enhance data discovery across biological disciplines and collaborative sites.

  Mathur R, et al

  2021

  Journal of Translational Medicine 19 (1): 461.
• Mapping of pathological change in chronic fatigue syndrome using the ratio of T1- and T2-weighted MRI scans.

  Thapaliya K et al

  2020

  NeuroImage Clinical 28.
• MCP-1 is Increased in Patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls.

  Groven N et al

  2020

  Brain, Behaviour & Immunity- health 4: 100067.
• ME/CFS Pathophysiology Investigated by Invasive Cardiopulmonary Exercise Testing and Autonomic Function Testing

  Squires J et al

  2023

  American Journal of Respiratory and Critical Care Medicine
• ME/CFS: Past, Present and Future.

  Weir W & Speight N

  2021

  Healthcare 9 : 984.
• ME/CFS: Past, Present and Future.

  Weir W & Speight N

  2021

  Healthcare 9 : 984.
• Mechanisms underlying chronic fatigue, a symptom too often overlooked II- From deregulated immunity to neuroinflammation and its consequences.

  Trautmann A

  2021

  Medecine Sciences (Paris) 37 (11): 1047-1054. [Article in French.]
• Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome.

  Okada T et al

  2004

  BMC Neurology 4: 14
• Mechanistic factors contributing to pain and fatigue in fibromyalgia and me/cfs: autonomic and inflammatory insights from an experimental medicine study.

  Eccles J et al

  2022

  Annals of the rheumatic diseases 81: 1719.
• Mechanistic factors contributing to pain and fatigue in fibromyalgia and me/cfs: autonomic and inflammatory insights from an experimental medicine study.

  Eccles J et al

  2022

  Annals of the rheumatic diseases 81: 1719.
• Medial prefrontal cortex deficits correlate with unrefreshing sleep in patients with chronic fatigue syndrome.

  Shan ZY et al

  2017

  NMR Biomedicine 30 (10).
• Memory impairments in chronic fatigue syndrome patients.

  Smith AP

  2022

  World Journal of Pharmaceutical and Medical Research 8 (6): 50-54.
• Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders.

  Tak LM et al

  2011

  Biological Psychology 87(2): 183-194.
• Meta-analysis investigating post-exertional malaise between patients and controls.

  Brown A and Jason LA

  2020

  Journal of Health Psychology 25 (13-14): 2053-2071.
• Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini review.

  Tomas C and Newton J.

  2018

  Biochemical Society Transactions 46 (3): 547-553.
• Metabolic features of chronic fatigue syndrome.

  Naviaux RK et al

  2016

  Proceedings of the National Academy of Sciences doi:10.1073/pnas.1607571113.
• Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

  Fluge O et al

  2016

  Journal of Clinical Immunology Insight doi: 10.1172/jci.insight.89376.
• Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.

  Germain A et al

  2018

  Molecular BioSystems 13 (2): 371-379.
• Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Che X et al

  2022

  International Journal of Molecular Sciences 23 (14): 7906.
• Metabolomic Evidence for Peroxisomal Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Che X et al

  2022

  International Journal of Molecular Sciences 23 (14): 7906.
• Metabolomics in Central Sensitivity Syndromes.

  Miller J et al

  2020

  Metabolites 10 (4): 164.
• Metabolomics study of the effect of Danggui Buxue Tang on rats with chronic fatigue syndrome.

  Miao X et al

  2022

  Biomedical Chromatography : e5379.
• Methylation profile of CD4+ T cells in chronic fatigue syndrome/myalgic encephalomyelitis.

  Brenu EW et al

  2014

  Journal of Clinical & Cellular Immunology 5(3): 228.
• MicroRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome.

  Al-Rawaf et al

  2019

  Pain Practice 19 (8): 848-860.
• Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function in ME/CFS Evolving from the Post COVID19 Syndrome

  Wirth KJ and Lohn M

  2023

  Preprints
• Minireview for Chronic Fatigue Syndrome and its Medical Attention recently.

  Son C

  2019

  Journal of Korean Medicine 40 (4): 84-90.
• miRNA profiling of circulating EVs in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Almenar-Perez E, et al

  2019

  Journal of Extracellular Vesicles , 7: 139.
• Mismatch between subjective and objective dysautonomia

  Novak P, et al.

  2024

  Scientific Reports 14: 2513
• Mitochondria and Immunity in Chronic Fatigue Syndrome.

  Anderson G, and Maes M

  2020

  Progress in Neuropsychopharmacological and Biological Psychiatry [Epub ahead of print].
• Mitochondria and immunity in chronic fatigue syndrome.

  Anderson G and Maes M

  2021

  Progress in Neuro-psychopharmacology & Biological Psychiatry 103: 109976.
• Mitochondria and immunity in chronic fatigue syndrome.

  Anderson G and Maes M

  2021

  Progress in Neuro-psychopharmacology & Biological Psychiatry 103: 109976.
• Mitochondrial abnormalities in the post-viral fatigue syndrome.

  Behan WMH et al

  1991

  Acta Neuropathologica 83(1): 61-65.
• Mitochondrial alterations in NK lymphocytes from ME/CFS patients.

  Silvestre I et al

  2019

  The Journal of Immunology 202 (1): 126.39.
• Mitochondrial complex activity in permeabilised cells of chronic fatigue syndrome patients using two cell types.

  Tomas C et al

  2019

  PeerJ 7: e6500.

  Funded by the ME Association
• Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview

  Mantle D, et al.

  2024

  International Journal of Molecular Sciences 25 (1): 574
• Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview

  Mantle D et al

  2020

  Preprints
• Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Booth NE et al

  2012

  International Journal of Clinical and Experimental Medicine 5(3): 208-220.
• Mitochondrial dysfunction in a family with psychosis and chronic fatigue syndrome.

  Torrell H et al

  2017

  Mitochodrion 34: 1-8.
• Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome.

  Smits B et al

  2011

  Mitochondrion 11(5): 735-738.
• Mitochondrial myopathy presenting as fibromyalgia: a case report.

  Abdullah M et al

  2012

  Journal of Medical Case Reports 6(1): 55.
• Mixed methods system for the assessment of post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an exploratory study

  Stussman B, et al.

  2024

  BMJ Neurology Open: 6: e000529
• Modulation of Beta-Adrenergic Autoantibodies Over Time in Post-Viral ME/CFS is Related to Fatigue and Pain Symptoms

  Busch L et al

  2023

  The Israel Medical Association Journal
• Modulatory effects of cognitive exertion on regional functional connectivity of the salience network in women with ME/CFS: A pilot study.

  Manca R et al

  2021

  Journal of the Neurological Science 422: 117326.
• Modulatory effects of cognitive exertion on regional functional connectivity of the salience network in women with ME/CFS: A pilot study.

  Manca R et al

  2021

  Journal of the Neurological Science 422: 117326.
• Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.

  Tate W et al

  2022

  Frontiers in Neurology 13: 877772.
• Molecular Mechanisms of Neuroinflammation in ME/CFS and Long COVID to Sustain Disease and Promote Relapses.

  Tate W et al

  2022

  Frontiers in Neurology 13: 877772.
• Molecular Study of Receptor for Advanced Glycation Endproduct Gene Promoter and Identification of Specific HLA Haplotypes Possibly Involved in Chronic Fatigue Syndrome

  Carlo-Stella N et al

  2009

  International Journal of Immunopathology and Pharmacology 22(3): 745-754.
• MTHFR and LC, CFS, POTS, MCAS, SIBO, EDS: Methylating the Alphabet

  Chambers P

  2023

  Qeios 2023
• Multi'omics of host-microbiome interactions in short- and long-term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Xiong R, et al

  2021

  Cell Host & Microbe 31 (2): 273-287.
• Multi-‘omics of host-microbiome interactions in short- and long-term Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Xiong R et al

  2021

  bioRxiv [Epub ahead of print.]
• Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome.

  Raijmakers et al

  2020

  Journal of Translational Medicine 18 (1): 448.
• Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.

  Unger ER et al

  2017

  American Journal of Epidemiology 185 (8): 617-626.
• Multidimensional Comparison of Cancer-Related Fatigue and Chronic Fatigue Syndrome: The Role of Psychophysiological Markers.

  Park HY

  2019

  Psychiatry Investigations 16 (1): 71-79,
• Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

  Natelson BH et al

  2017

  Journal of Neurological Science 375: 411-416.
• Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

  Natelson BH et al

  2017

  Journal of Neurological Science 375: 411-416.
• Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.

  Shan ZY et al

  2022

  Frontiers in Neurology 13: 954142.
• Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Petter, E et al

  2022

  Journal of Translational Medicine 20: 580.
• Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Petter, E et al. et al

  2022

  Journal of Translational Medicine 20: 580.
• Muscle-tendon weakness contributes to chronic fatigue syndrome in Gaucher's disease.

  Roca-Espiau M et al

  2019

  Journal of Orthopeadic Surgeon Research 14 (1): 383.
• Myalgic Encephalitis/Chronic Fatigue Syndrome: Diagnostic and Therapeutic Approach and Biological Research

  Sato W

  2023

  National library of Medicine
• Myalgic Encephalomyelitis (ME) outbreaks can be modelled as an infectious disease: a mathematical reconsideration of the Royal Free Epidemic of 1955.

  Waters FG, et al

  2020

  Fatigue: Biomedicine, Health and Behaviour 8 (2): 70-83.
• Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?

  Morris G, et al

  2019

  Metabolic Brain Disease 1-31.
• Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Common Data Element item content analysis

  Slavin M et al

  2023

  PLoS One
• Myalgic encephalomyelitis/ chronic fatigue syndrome as a breakdown of homeostasis.

  Marks DF

  2021

  Qeios.
• Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19: is there a connection?

  AlMuhaissen S et al

  2023

  Current Medical Research and opinion
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and mitochondria: A review.

  Pandley AA

  2022

  Masters Thesis, Cornell University
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview.

  Deumer U-S, et al

  2021

  Journal of Clinical Medicine 10 (20): 4786.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): The Biology of a Neglected Disease

  Arron H, et al.

  2023

  Heliyon [Preprint]
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease.

  Sotzny F et al

  2018

  Autoimmune Reviews [Epub ahead of print]
• Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.

  Halpin P et al

  2017

  Journal of Medical Virology 89 (9): 1636-1645.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a Hyper-Regulated Immune System Driven by an Interplay Between Regulatory T Cells and Chronic Human Herpesvirus Infections.

  Sepulveda N et al

  2019

  Frontiers in Immunology 10:2684.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity,

  Proal AD and Marshall T

  2018

  Frontiers in Pediatrics 6:374.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice.

  Ohba T et al

  2019

  Biological and Pharmaceutical Bulletin 42 (7).
• Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations

  Mandarano AH et al

  2019

  Journal of Clinical Investigation 130 (3): 1491-1505.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Metabolic Disease or Disturbed Homeostasis due to Focal Inflammation in the Hypothalamus?

  Hatziagelaki E et al

  2018

  Journal of Pharmacology and Experimental Therapeutics 367 (1): 155-167.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.

  Rivera C, et al

  2019

  Diagnostics 9 (3).
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?

  Gandasegui IM et al

  2021

  Medicina 57: 1030.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?

  Gandasegui IM et al

  2021

  Medicina 57: 1030.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?

  Gandasegui IM et al

  2021

  Medicina 57: 1030.
• Myalgic encephalomyelitis/chronic fatigue syndrome: a review of the currente vidence.

  Ludwig B et al. et al

  2023

  Neurologist [Article in German]
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption.

  Tolle M et al

  2020

  Journal of Clinical Medicine 9 (8).
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

  Ariza ME

  2021

  Biomolecules 11 (2): 185.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

  Ariza ME

  2021

  Biomolecules 11 (2): 185.
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: When Suffering Is Multiplied.

  Komaroff AL

  2021

  Healthcare 2021, 9: 919.
• Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  Cabanas H et al

  2019

  Frontiers in Immunology [Epub ahead of print]
• Nationwide Epidemiological Characteristics of Chronic Fatigue Syndrome in South Korea.

  Lim EJ et

  2021

  Journal of Translational Medicine BMC , 19 (1): 502.
• Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study

  Querec, T et al

  2023

  Journal of translational medicine
• Network Analysis of Symptoms Co-Occurrence in Chronic Fatigue Syndrome.

  Kujawski S et al

  2021

  International Journal of Environmental Research and Public Health 18 (20): 10736.
• Network structure underpinning (dys)homeostasis in chronic fatigue syndrome; Preliminary findings.

  Clark JE et al

  2019

  PLoS One 14 (3).
• Neural consequences of post-exertion malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Cook DB et al

  2017

  Brain and Behavioural Immunology 62: 87-99.
• Neural correlates of the chronic fatigue syndrome – an fMRI study.

  de Lange FP et al

  2004

  Brain 127(9): 1948-1957.
• Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla.

  Godlewska BR et al

  2021

  Psychopharmacology 239 (1): 163-171.
• Neuroendocrine Aspects of Chronic Fatigue Syndrome.

  Papanicolaou DA et al

  2004

  NeuroImmunoModulation 11(2): 65-74.
• Neuroendocrine disorder in chronic fatigue syndrome.

  Tomic S et al

  2017

  Turkish Journal of Medical Science 47 (4): 1097-1103.
• Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review.

  Shan Z et al

  2020

  Journal of Translational Medicine 18 (1): 335.
• Neuroinflammation and cytokines in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS): A critical review of research methods,

  VanElzakker MB et al

  2018

  Frontiers in Neurology [Epub ahead of print].
• Neuroinflammation and cytokines in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS): A critical review of research methods,

  VanElzakker MB et al

  2018

  Frontiers in Neurology 9:1033.
• Neuroinflammation disorders exacerbated by environmental stressors.

  O'Callaghan JP and Miller DB

  2019

  Metabolism Clinical and Experimental 100: 153951.
• Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study.

  Nakatomi Y et al

  2014

  Journal of Nuclear Medicine 55(6): 945-950.
• Neuroinflammation in the Brain of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (Article in Japanese)

  Nakatomi Y et al

  2018

  Brain and Nerves 70 (1): 19-25.
• Neuroinflammation, Oxidative Stress, and Neurogenesis in a Mouse Model of Chronic Fatigue Syndrome, and the Treatment with Kampo Medicine.

  He Q et al

  2020

  Biological and Pharmaceutical Bulletin 43 (1): 110-115.
• Neurologic Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review. (Article in Japanese)

  Komaroff AL et al

  2018

  Brain and Nerve 70 (1): 41-54.
• Neurological aspects of human parvovirus B19 infection: a systematic review.

  Barah F, et al

  2014

  Reviews in Medical Virology 24(3): 154-168.
• Neuropathology and Neurological Manifestations in ME/CFS and Long COVID with focus on Post-Exertional Symptom Exacerbation: a Literature Review

  Rodenburg, S

  2023

  Utrecht University
• Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions

  Bratty, AJ

  2024

  Integrative Medicine: A Clinician's Journal 22 (6): p20
• Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings.

  Rasouli O et al

  2019

  Neuropsychology 33 (5): 658-669.
• Neuropsychological functioning in chronic fatigue syndrome: a review.

  Michiels V and Cluydts R

  2001

  Acta Psychiatrica Scandinavica 103(2): 84-93.
• Neuropsychological performance and noradrenaline function in chronic fatigue syndrome under conditions of high arousal.

  Morriss RK et al

  2002

  Psychopharmacology 163(2): 166-173.
• Neurovascular Dysregulation and Acute Exercise Intolerance in ME/CFS: A Randomized, Placebo-Controlled Trial of Pyridostigmine.

  Joseph P et al

  2022

  Chest 162 (5): 1116-1126.
• New government delivery plan to support children with myalgic encephalomyelitis

  Lepkowska D

  2020

  British Journal of Child Health
• Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.

  Morris G et al

  2017

  Molecular Neurobiology 54 (6): 4271-4291.
• No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after

  Hanevik K, et al

  2022

  Giardia infection. JGH Open (2022):1-4.
• No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after

  Hanevik K, et al

  2022

  Giardia infection. JGH Open (2022):1-4.
• No difference in serum levels of B-cell activating receptor and antibodies against cytolethal distending toxin B and flagellin in post-infectious irritable bowel syndrome and chronic fatigue syndrome after

  Hanevik K, et al

  2022

  Giardia infection. JGH Open (2022):1-4.
• No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  Ueland M et al

  2022

  Translational Psychiatry 12: 277.
• No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.

  Burbelo PD, et al

  2012

  American Journal of Translational Research 4(4): 443-451.
• No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome.

  Burbelo PD et al

  2012

  American Journal of Translational Research 4(4): 443-451.
• No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11 C]-PK11195.

  Raijmakers R, et al

  2022

  Neurology Neuroimmunology and Neuroinflammation 9 (1): e1113.
• No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11 C]-PK11195.

  Raijmakers R et al

  2022

  Neurology Neuroimmunology and Neuroinflammation 9 (1): e1113.
• Nonrestorative sleep and symptoms after a febrile illness in patients with fibrositis and chronic fatigue syndromes.

  Moldofsky H

  1989

  The Journal of Rheumatology Supplement 19: 150-53.
• Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.

  Nguyen T et al

  2017

  Asian Pacific Journal of Allergy and Immunology 35 (2): 75-81.
• Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  van Campen CLMC et al

  2021

  Frontiers in Medicine (Lausanne) 7: 602894.
• Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Van Campen CM, et al

  2021

  Frontiers in Medicine (Lausanne) 7: 602894.
• Objective evidence of cognitive complaints in Chronic Fatigue Syndrome: A BOLD fMRI study of verbal working memory.

  Lange G et al

  2005

  NeuroImage 26(2): 513-524.
• Objective sleep measures in chronic fatigue syndrome patients: A systematic review and meta-analysis

  Mohamed A et al

  2023

  Science Direct
• Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report

  Stein E et al

  2023

  Journal of Clinical Medicine
• Ocular manifestations of chronic fatigue and immune dysfunction syndrome.

  Potaznick W and Kozol N

  1994

  Optometry and Vision Science 69 (10): 811-4.
• Old muscle in young body: an aphorism describing the Chronic Fatigue Syndrome,

  Tiziana P et al

  2018

  European Journal of Translational Myology 28 (3).
• One-Year Follow-up of Young People with ME/CFS Following Infectious Mononucleosis by Epstein-Barr Virus

  PrIcoco R et al

  2023

  Med RXIV
• Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.

  Wallis A, et al

  2018

  Journal of Translational Medicine 16 (1): 24.
• Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.

  Wallis A, et al

  2018

  Journal of Translational Medicine 16 (1): 24.
• Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.

  Wallis A, et al

  2018

  Journal of Translational Medicine 16 (1): 24.
• Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Vernon SD, et al

  2022

  Frontiers in Medicine 9: 917019.
• Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Vernon SD et al

  2022

  Frontiers in Medicine 9: 917019.
• Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

  Van Campen C et al

  2023

  IBRO Neuroscience Reports
• Orthostatic Intolerance and Chronotropic Incompetence in Patients With Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

  Miwa K

  2023

  Circulation Reports 5 (2): 55-61.
• Orthostatic intolerance in chronic fatigue syndrome.

  Garner R and Baraniuk J

  2019

  Journal of Translational Medicine 17: 185.
• Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  van Campen CMC and Visser FC

  2022

  Healthcare 10 (10): 2058.
• Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  van Campen CMC and Visser FC

  2022

  Healthcare 10 (10): 2058.
• Orthostatic stress testing in myalgic encephalomyelitis/chronic fatigue syndrome patients with or without concomitant fibromyalgia: effects on pressure pain thresholds and temporal summation.

  Van Campen CM, et al

  2020

  Clinical and Experimental Rheumatology 39 (3): S39-S47.
• Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Van Campen C, et al

  2021

  Medicina 58 : 28.
• Oxidative stress caused by a dysregulated Wnt/beta-catenin signalling pathway is involved in abnormal placenta formation in pregnant mice with chronic fatigue syndrome.

  Zhao H et al

  2020

  Zygote.
• Pain-related post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A systematic review and three-level meta-analysis.

  Barhost EE et al

  2021

  Pain Medicine: pnab308. [Epub ahead of print.]
• Pain-related post-exertional malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia: A systematic review and three-level meta-analysis.

  Barhost EE et al

  2022

  Pain Medicine 23(6): 1144-1157.
• Paradigm shift to disequilibrium in the genesis of orthostatic intolerance in patients with myalgic encephalomyelitis and chronic fatigue syndrome.

  Miwa K and Inoue Y

  2020

  International Journal of Cardiology. Hypertension 5:100032.
• Paradigme shift to disequilibrium in the genesis of orthostatic intolerance in patients with chronic fatigue syndrome.

  Miwa K

  2019

  European Heart Journal 40 (1).
• Parasympathetic activity is reduced during slow-wave sleep, but not resting wakefulness, in patients with chronic fatigue syndrome.

  Fatt SJ et al

  2019

  Journal of Clinical Sleep Medicine [Epub ahead of print].
• Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Missailidis D, et al

  2019

  Diagnostics 9 (3): 80.
• Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  Fluge Ø, et al

  2021

  The Journal of Clinical Investigations 131 (14): e150377.
• Pathophysiology of a Central Cause of a Post-Polio Fatigue Syndrome.

  Bruno RL, et al

  1995

  Annals of the New York Academy of Sciences 753: 257-275.
• Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Wirth, KJ et al

  2021

  Journal of Translational Medicine 19 (1): 162.
• Pathway Phenotypes Underpinning Depression, Anxiety, and Chronic Fatigue Symptoms Due to Acute Rheumatoid Arthritis: A Precision Nomothetic Psychiatry Analysis.

  Smesam HN, et al

  2022

  Journal of Personalized Medicine 12 (3): 476.
• Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Jason A, et al

  2021

  Chronic Illness :17423953211043106.
• Patients with chronic fatigue syndrome have reduced absolute cortical blood flow.

  Yoshiuchi K et al

  2006

  Clinical Physiology and Functional Imaging 26(2): 83-86.
• Patients with ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) and chronic pain report similar level of sickness behavior as individuals injected with bacterial endotoxin at peak inflammation.

  Jonsjo MA et al

  2019

  Brain, Behavior & immunity - Health 2:100028.
• Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance Disease.

  Morizot R et al

  2021

  Journal of Clinical Medicine 10 (15): 3374.
• Patterns of abnormal visual attention in Myalgic Encephalomyelitis (ME).

  Hutchinson CV and Badham SP

  2013

  Optometry and Vision Science , 90 , 607-614.
• Peak Oxygen Uptake in Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis: A Meta-Analysis.

  Franklin JD, et al

  2018

  International Journal of Sports Medicine 40 (2): 77-87.
• Pediatric and Adult Patients with ME/CFS following COVID-19: A Structured Approach to Diagnosis Using the Munich Berlin Symptom Questionnaire (MBSQ)

  Peo L et al

  2021

  bioRxiv [Preprint]
• Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

  Scherbakov N, et al

  2020

  ESC Heart Failure 7 (3): 1064-1071.
• Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.

  Scherbakov N, et al

  2020

  ESC Heart Failure 7 (3): 1064-1071.
• Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome.

  Russell A et al

  2018

  Psychoneuroendocrinology [Epub ahead of print].
• Perspective: Cell Danger Response Biology – The New Science that Connects Environmental Health with Mitochondria and the Rising Tide of Chronic Illness.

  Naviaux RK

  2019

  Mitochondrion [Epub ahead of print].
• Pharmacological activation of AMPK and glucose uptake in cultured human skeletal muscle cells from patients with ME/CFS.

  Brown AE et al

  2018

  Bioscience Reports 38 (3): BSR20180242.
• Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study.

  Jahanbani F et al

  2022

  PLoS ONE 17(8): e0272703.
• Physical Activity and Sleep in Chronic Fatigue Syndrome and Fibromyalgia Syndrome: Associations with Symptom Severity in the General Population Cohort LifeLines.

  Joustra ML et al

  2018

  Pain Research and Management 2018: 8.
• Physical Activity Measures in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Correlations Between Peak Oxygen Consumption, the Physical Functioning Scale of the SF-36 Questionnaire, and the Number of Steps From an Activity Meter.

  van Campen CM et al

  2020

  Journal of Translational Medicine 18 (1): 228.
• Physiological assessment of orthostatic intolerance in chronic fatigue syndrome.

  Natelson BH et al

  2022

  Journal of Translational Medicine 20: 95.
• Physiological measures in participants with chronic fatigue syndrome, multiple sclerosis and healthy controls following repeated exercise: a pilot study.

  Hodges LD, et al

  2017

  Clinical Physiology and Functional Imaging
• Pitfalls in cytokine measurements – Plasma TGF-β1 in chronic fatigue syndrome.

  Roerink ME et al

  2018

  Netherlands Journal of Medicine 76 (7): 310-313.
• Plasma cytokines in women with chronic fatigue syndrome.

  Fletcher MA et al

  2009

  Journal of Translational Medicine 7:96.
• Plasma metabolomics reveals disrupted response and recovery following maximal exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Germain A et al

  2022

  JCI Insight 7(9): e157621.
• Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.

  Milivojevic M et al

  2020

  PLoS One 15 (7).
• Platelet Storage Pool Deficiency and Elevated Inflammatory Biomarkers Are Prevalent in Postural Orthostatic Tachycardia Syndrome.

  Gunning WT et al

  2022

  Cells 11: 774.
• Polio Vaccination and Chronic Fatigue Syndrome.

  Smith AP and Thomas M

  2021

  Asian Journal of Research in Infectious Diseases 8(4): 43-49.
• Polyphenols as possible alternative agents in chronic fatigue: a review.

  Ullah H et al

  2022

  Phytochemistry Reviews.
• Poor self-reported sleep quality and health-related quality of life in patients with chronic fatigue syndrome/myalgic encephalomyelitis.

  Castro-Marrero J et al

  2018

  Journal of Sleep Research 27 (6).
• Positive Effects of Probiotic Therapy in Patients with Post-Infectious Fatigue

  Obermoser et al

  2023

  Metabolites
• Possible involvement of the autonomic nervous system in cervical muscles of patients with myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). BMC

  Matsui ,T et al

  2021

  Musculoskelet Disorders 22 (1): 419.
• Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome.

  Bakheit AM et al

  1992

  BMJ 304(6833): 1010-1012.
• Post Viral Pain, Fatigue, and Sleep Disturbance Syndromes: Current knowledge and Future Directions

  Tackey C et al

  2023

  Canadian Journal of Pain
• Post-acute Sequelae of SARS Co-V2 and Chronic Fatigue/Myalgic Encephalitis Share Similar Pathophysiologic Mechanisms of Exercise Limitation

  Jothi S et al

  2023

  American Journal of Respiratory and Critical Care Medicine
• Post-bacterial infection chronic fatigue syndrome is not a latent infection.

  Melenotte C, et al

  2019

  Medecine et Maladies Infectieuses 49 (2): 140-149.
• Post-COVID sequelae effect in chronic fatigue syndrome: SARS-CoV-2 triggers latent adenovirus in the oral mucosa

  Hannestad U et al

  2023

  Frontiers in Medicine
• Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome. Post-COVID syndrome with fatigue and exercise intolerance: myalgic encephalomyelitis/chronic fatigue syndrome].

  Renz-Polster H and Scheibenbogen C.

  2022

  Innere Medizin 63 (8): 830-839. [Article in German.]
• Post-Ebolavirus disease syndrome: what do we know?

  Carod-Artal

  2015

  Expert Review of Anti-Infective Therapy 13(10): 1185-1187.
• Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

  Vernon S et al

  2023

  Work
• Post-exertional malaise in daily life and experimental exercise models in patients with myalgic encephalomyelitis/chronic fatigue syndrome

  Vollestad N, Mengshoel A

  2023

  Frontiers in Physiology
• Post-exertional malaise in daily life and experimental exercise models in patients with myalgic encephalomyelitis/chronic fatigue syndrome

  Vollestad N, Mengshoel A

  2023

  Frontiers in Psychology
• Post-Exertional Malaise in Patients with ME and CFS with Comorbid Fibromyalgia.

  McManimen SL and Jason LA.

  2017

  SRL Neurology and Neurosurgery 3 (1): 22-27.
• Post-exertional malaise is associated with greater symptom burden and psychological distress in patients diagnosed with Chronic Fatigue Syndrome.

  May M et al

  2019

  Journal of Psychosomatic Research 129: 109893.
• Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases.

  McGregor N et al

  2019

  Diagnostics 9 (3).
• Post-Exertional Malaise May Be Related to Central Blood Pressure, Sympathetic Activity and Mental Fatigue in Chronic Fatigue Syndrome Patients.

  Kujawski S, et al

  2021

  Journal of Clinical Medicine 10 (11): 2327.
• Post-exertional symptoms distinguish myalgic encephalomyelitis/chronic fatigue syndrome subjects from healthy controls.

  Mateo L et al

  2020

  Work 66 (2):265-275.
• Post-infection fatigue syndrome following Q fever.

  Ayres JG, et al

  1998

  QJM 91(2): 105-123.
• Post-infectious fatigue syndrome in dengue infection.

  Seet RCS, et al

  2007

  Journal of Clinical Virology, 38(1): 1-6/
• post-Infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study.

  Hickie I

  2006

  British Medical Journal 333: 575.
• Post-viral fatigue and COVID-19: lessons from past epidemics.

  Islam M, et al

  2020

  Fatigue: Biomedicine, Health and behavior 8:2, 61-69.
• Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway.

  Naess H, et al

  2010

  In Vivo 24 (2): 185-188.
• Postinfective Fatigue Syndrome Is Not Associated with Altered Cytokine Production.

  Vollmer-Conna U et al

  2007

  Clinical Infectious Diseases 45(6): 732-735.
• Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis

  Bai N, Richardson C

  2022

  Chronic diseases and translational medicine
• Posttreatment Lyme disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis 

  Natalie A, Richardson C

  2023

  Chronic disease and translational medicine
• Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: further evidence for central nervous system dysfunctioning.

  Nijs J and Ickmans K

  2013

  Journal of Internal Medicine 273(5): 498-500.
• Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: further evidence for central nervous system dysfunctioning.

  Nijs J and Ickmans K

  2013

  Journal of Internal Medicine 273(5): 498-500.
• Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome.

  Hoad A et al

  2008

  QJM 101(12): 961-965.
• Postural tachycardia syndrome is associated with significant symptoms and functional impairment predominantly affecting young women: a UK perspective.

  McDonald C et al

  2014

  BMJ Open 4(6): e004127.
• Postural Tachycardia Syndrome: A Heterogeneous and Multifactorial Disorder.

  Benarroch EE

  2012

  Mayo Clinic Proceedings 87(12): 1214-1225.
• Potential causal factors of CFS/ME: a concise and systematic scoping review of factors researched.

  Muller AE, et al

  2021

  Journal of Translational Medicine 18 (1): 484.
• Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review

  Preez SD, et al

  2021

  International Journal of Environmental Resources and Public Health 18 (20): 10708.
• Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review

  Preez SD et al

  2021

  International Journal of Environmental Resources and Public Health 18 (20): 10708.
• Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases.

  Gottschalk, CG et al

  2023

  Infectious Agents and Cancer 18 : 7.
• Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Gravelsina S et al

  2021

  Biomolecules 11: 1189.
• Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Gravelsina S, et al

  2021

  Biomolecules 11: 1189.
• Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).

  Lupo GFD, et al

  2021

  Scientific Reports 11 (1): 7043.
• Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.

  Cabanas H et al

  2021

  Frontiers in Immunology 12: 687806.
• Pre-illness data reveals differences in multiple metabolites and metabolic pathways in those who do and do not recover from infectious mononucleosis.

  Jason LA, et al

  2022

  Molecular Omics [Epub ahead of print].
• Pre-illness data reveals differences in multiple metabolites and metabolic pathways in those who do and do not recover from infectious mononucleosis.

  Jason LA et al

  2022

  Molecular Omics [Epub ahead of print].
• Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome from Early Symptoms of COVID-19 Infection

  Hua C et al

  2023

  Psych 23
• Predicting post-exertional malaise in Gulf War Illness based on acute exercise responses.

  Boruch AE et al

  2021

  Life Science:119701.
• Predictors for Developing Severe Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Following Infectious Mononucleosis.

  Jason LA, et al

  2022

  Journal of Rehabilitation Therapy 4(1): 1-5.
• Predictors of Chronic Fatigue Syndrome and Mood Disturbance After Acute Infection.

  Sandler CX, et al

  2022

  Frontiers in Neurology 13: 935442.
• Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus.

  Vernon SD, et al

  2006

  BMC Infectious Diseases 6:15.
• Prevalence of and risk factors for severe cognitive and sleep symptoms in ME/CFSand MS

  Jain V et al

  2017

  BMC Neurology 17: 117.
• Prevalence of Aspergillus-Derived Mycotoxins (Ochratoxin, Aflatoxin, and Gliotoxin) and Their Distribution in the Urinalysis of ME/CFS Patients.

  Wu TY et al

  2022

  International Journal of Environmental Research and Public Health 19: 2052.
• Prevalence of Fibromyalgia and Chronic Fatigue Syndrome among Individuals with Irritable Bowel Syndrome: An Analysis of United States National Inpatient Sample Database
• Preventing the induction of acid saline-induced fibromyalgia pain in mice by electroacupuncture or APETx2 injection.

  Yen LT et al

  2020

  Acupuncture in Medicine [Epub ahead of print].
• Processing of Laser-Evoked Potentials in Patients with Chronic Whiplash-Associated Disorders, Chronic Fatigue Syndrome, and Healthy Controls: A Case-Control Study.

  Goudman L et al

  2020

  Pain Medicine 21 (10): 2553-2563.
• Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology.

  Nepotchatykh E et al

  2020

  Scientific Reports 10 (1): 19620.
• Progressive brain changes in patients with chronic fatigue syndrome: A longitudinal MRI study.

  Shan ZY, et al

  2016

  Journal of Magnetic Resonance Imaging doi: 10.1002/jmri.25283.
• Prolonged acetylcholine-induced vasodilatation in the peripheral microcirculation of patients with chronic fatigue syndrome.

  Khan F et al

  2003

  Clinical Physiology and Functional Imaging 23(5): 282-285.

  Funded by the ME Association
• Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load.

  Cameron B, et al

  2006

  Journal of Infectious Diseases 193(5): 664-671.
• Properties of measurements obtained during cardiopulmonary exercise testing in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.

  Davenport T, et al

  2020

  Work 66 (2): 247-256.
• Prospective Biomarkers from Plasma Metabolomics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Implicate Redox Imbalance in Disease Symptomatology.

  Germain A et al

  2018

  Metabolites 8 (4).
• Protective Effect of Hemin Against Experimental Chronic Fatigue Syndrome in Mice: Possible Role of Neurotransmitters.

  Thakur V et al

  2020

  Neurotoxic Research 38:359 369.
• Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls

  Giloteaux L et al

  2023

  Journal of Translational Medicine
• Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome.

  Brooks J et al

  2000

  The British Journal of Radiology 73(875): 1206-1208.
• Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome.

  Chaudhuri A et al

  2003

  NeuroReport 14(2): 225-228.

  Funded by the ME Association
• Psychogenic Pseudosyncope: Real or Imaginary? Results from a Case-Control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients.

  Van Campen C, et al

  2022

  Medicina 58: 98.
• Psychometric evaluation of the DePaul Symptom Questionnaire-Short Form (DSQ-SF) among adults with Long COVID, ME/CFS, and healthy controls: A machine learning approach

  McGarrigle W,J, et al.

  2024

  Journal of Health Psychology: 0 (0)
• Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host-implications for post Q fever infection fatigue syndrome and other chronic sequelae.

  Marmion BP, et al

  2009

  QJM 102 (10): 673-684.
• Quantitative Assessment of Cerebral Ventricular Volumes in Chronic Fatigue Syndrome.

  Lange G et al

  2001

  Applied Neuropsychology 8(1): 23-30.
• Questioning Biomedicine's Privileging of Disease and Measurability.

  Kroll C

  2021

  AMA Journal of Ethics 23 (7): E537-541.
• Radiation exposure and mitochondrial insufficiency in Chronic Fatigue and Immune Dysfunction Syndrome

  Rusin A et al

  2021

  Medical Hypothesis 154: 110647.
• Radiation exposure and mitochondrial insufficiency in Chronic Fatigue and Immune Dysfunction Syndrome

  Rusin A et al

  2021

  Medical Hypothesis 154: 110647.
• Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.

  Montoya JG et al

  2013

  Journal of Medical Virology 85(12): 2101-2109.
• Randomized, double-blinded, placebo-controlled pilot study: Efficacy of faecal microbiota transplantation on chronic fatigue syndrome

  Salonen T et al

  2023

  Journal of Translational Medicine 21: 513
• Re-analysis of Genetic Risks for Chronic Fatigue Syndrome From 23andMe Data Finds Few Remain.

  Bedford FL and Tzovaras BG

  2021

  Frontiers in Pediatrics 9: 590040.
• Re-visiting professional ethics in psychotherapy: Reflections on the use of talking therapies as a supportive adjunct for myalgic encephalomyelitis / chronic fatigue syndrome and ‘medically unexplained symptoms’

  Hunt J, Blease C

  2023

  OSF Preprints
• Reciprocal associations between daily need-based experiences, energy, and sleep in chronic fatigue syndrome,

  Campbell R et al

  2018

  Health Psychology 37 (12): 1168-1178.
• Recognizing the leaky gut as a trans-diagnostic target for neuro-immune disorders using clinical chemistry and molecular immunology assays,

  Simeonova D, et al

  2018

  Current Topics in Medicinal Chemistry 18 (19): 1641-1655.
• Recovery from Exercise in Persons with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Moore G et al

  2023

  Medicina
• Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome.

  Metselaar PL, et al

  2021

  Scientific Reports 11 (1): 4541.
• Redox imbalance Link s COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.

  Paul BD et al

  2021

  Proceedings of the National Academy of Sciences of the Unites States of America 118 (34): e2024358118.
• Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome.

  Beaumont A et al

  2012

  PLoS ONE 7(11): e49518.
• Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome.

  Giloteaux L, et al

  2016

  Microbiome Jun 23; 4(1):30. doi: 10.1186/s40168-016-0171-4.
• Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation.

  Nguyen T et al

  2018

  Asian Pacific Journal of Allergy and Immunology [Epub ahead of print]
• Reduced Heart Rate Variability in Patients with Medically Unexplained Physical Symptoms: A Meta-Analysis of HF-HRV and RMSSD.

  Vreijling SR, et al

  2020

  Psychosomatic Medicine
• Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis

  Escorihuela RM, et al

  2020

  Journal of Translational Medicine 18: 4.
• Reduced Parasympathetic Reactivation during Recovery from Exercise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  van Oosterwijck J et al

  2021

  Journal of Clinical Medicine 10 (19): 4527.
• Reduction of serotonin transporters of patients with chronic fatigue syndrome.

  Yamamoto S et al

  2004

  NeuroReport 15(17): 2571-2574.
• Regional grey and white matter volumetric changes in myalgic encephalomyelitis (chronic fatigue syndrome): a voxel-based morphometry 3 T MRI study.

  Puri BK et al

  2012

  The British Journal of Radiology 85(1015): e270-e273.
• Relation of Urinary Mercury Level to Chronic Fatigue Syndrome among Workers of Artisanal and Small-scale Gold Mining: A Study of 3 Districts in West Nusa Tenggara Province and Lebak District of Banten Province, Indonesia.

  Adi NP et al

  2022

  Acta Medica Philippina 56 (19): 34-38.
• Relationship between Cardiopulmonary, Mitochondrial and Autonomic Nervous System Function Improvement after an Individualised Activity Programme upon Chronic Fatigue Syndrome Patients. (On Behalf Of The European Network On Me/Cfs Euromene.)

  Kujawki S et al

  2021

  Journal of Clinical Medicine 10 (7): 1542.
• Relationship between Cardiopulmonary, Mitochondrial and Autonomic Nervous System Function Improvement after an Individualised Activity Programme upon Chronic Fatigue Syndrome Patients. (On Behalf Of The European Network On Me/Cfs Euromene.)

  Kujawki S et al

  2021

  Journal of Clinical Medicine 10 (7): 1542.
• Relationship Between Exercise-induced Oxidative Stress Changes and Parasympathetic Activity in Chronic Fatigue Syndrome: An Observational Study and in Patients and Healthy Subjects.

  Polli A, et al

  2019

  Clinical Therapy 41 (4): 641-655.

  Funded by the ME Association
• Relationships Between Chronic Fatigue Syndrome, Experiential Avoidance, and Health-Related Quality of Life in Cervical Cancer Cases Mediated by Depression

  Sakkaki S et al

  2024

  Women, Health, Bull
• Relative increase in choline in the occipital cortex in chronic fatigue syndrome.

  Puri BK et al

  2002

  Acta Psychiatrica Scandinavica 106(3): 224-226.
• Repeated maximal exercise tests of peak oxygen consumption in people with myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review and meta-analysis.

  Franklin JD and Graham M

  2022

  Fatigue: Biomedicine, Health & Behavior 10 (3): 119-135.
• Repetitive Transcranial Magnetic Stimulation Ameliorates Symptoms in Patients with Myalgic Encephalomyelitis (Chronic Fatigue Syndrome)

  Miwa K, Inoue Y

  2023

  IBR Neuroscience Reports
• Reproducibility of Measurements Obtained During Cardiopulmonary Exercise Testing in Individuals With Fatiguing Health Conditions: A Case Series.

  Larson B, et al

  2019

  Cardiopulmonary Physical Therapy Journal [Epub ahead of print].
• Research progress in the treatment of sleep disorder in chronic fatigue syndrome with external therapy of Traditional Chinese Medicine

  Feng C, et al

  2023

  International Journal of Chinese medicine
• Respiratory dysfunction in persistent somatic symptoms: A systematic review of observational studies

  Niwa S, et al.

  2024

  Journal of Psychosomatic Research: 111607
• Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME).

  Ashmed NS et al

  2018

  Vision 2 (10): 2.
• Reversible widespread brain 18 F-FDG PET hypometabolism in chronic fatigue syndrome treated by hyperbaric oxygen therapy.

  Mairal E et al

  2021

  Europe Journal of Nuclear Medicine and Molecular Imaging 48 (5): 1680-1681.
• Review of the Midbrain Ascending Arousal Network Nuclei and Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM).

  Baraniuk JN

  2022

  Brain Science 12: 132.
• Review of the Quality Control Checks Performed by Current Genome-Wide and Targeted-Genome Association Studies on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Grabowska A, et al

  2020

  Frontiers in Pediatrics 8: 293.
• Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and its potential application to disease diagnosis.

  Sepúlveda N, et al

  2022

  Frontiers in Medicine 9 :921101.
• Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and its potential application to disease diagnosis.

  Sepúlveda N et al

  2022

  Frontiers in Medicine 9 :921101.
• Revisiting IgG antibody reactivity to Epstein-Barr virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and its potential application to disease diagnosis.

  Sepúlveda N, et al

  2022

  medRxiv [Preprint].
• Rhinitis Symptoms in Chronic Fatigue Syndrome.

  Baraniuk JN, et al

  1998

  Annals of Allergy, Asthma & Immunology 81(4): 359-365.
• Right Arcuate Fasciculus Abnormality in Chronic Fatigue Syndrome.

  Zeineh MM et al

  2015

  Radiology 274(2): 517-526.
• Risks for Developing ME/CFS in College Students Following Infectious Mononucleosis: A Prospective Cohort Study.

  Jason LA, et al

  2020

  Clinical Infectious Diseases 73 (11): e3740-e3746.
• Risks for Developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in College Students Following Infectious Mononucleosis: A Prospective Cohort Study

  Jason LA, et al.

  2021

  Clinical Infectious Diseases 73 (11): e3740–e3746
• Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.

  Eaton N et al

  2018

  BMC Pharmacology and Toxicology 19 (1): 12.
• Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome.

  Rekeland IG et al

  2019

  Clinical Therapeutics 41 (5): 806-814.
• Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.

  Brenu EW et al

  2014

  International Immunology 26(4): 233-242.
• Role of Gut Microbiota and Probiotic in Chronic Fatigue Syndrome. In: Kaur I.P., Deol P.K., Sandhu S.K. (eds)

  Sharma A, et al

  2022

  Probiotic Research in Therapeutics Springer, Singapore.
• Role of infection and neurologic dysfunction in chronic fatigue syndrome.

  Komaroff AL and Cho TA

  2011

  Seminars in Neurology 31(3): 325-337.
• Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers'?

  Wood E et al

  2020

  Chronic Diseases and Translational Medicine 7 (1): 14-26.
• Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.

  Apostolou E et al

  2022

  Frontier in Immunology 13: 949787.
• Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.

  Apostolou E et al

  2022

  Frontier in Immunology 13: 949787.
• Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.

  Apostolou E et al

  2022

  Frontier in Immunology 13: 949787.
• Saliva fatigue biomarker index as a marker for severe myalgic encephalomyelitis/chronic fatigue syndrome in a community based sample.

  Jason LA, et al

  2021

  Fatigue: Biomedicine, Health & Behavior
• Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Lee JS, et al

  2021

  Frontiers in Medicine (Lausanne) 8: 656692.
• Salivary DNA Loads for Human Herpesviruses 6 and 7 Are Correlated With Disease Phenotype in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Lee JS et al

  2021

  Frontiers in Medicine (Lausanne) 8: 656692.
• Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy.

  Oaklander A and Nolano M

  2019

  JAMA Network [Epuba ahead of print].
• Searching for Serum Antibodies to Neuronal Proteins in Patients With Myalgic Encephalopathy/Chronic Fatigue Syndrome.

  Giannoccaro MP et al

  2019

  Clinical Therapeutics 41 (5): 836-847.
• Sensory Neuronopathy and Autoimmune Diseases.

  Martinez ARM et al

  2012

  Autoimmune Diseases
• Serious long-term health consequences of Q-fever and Legionnaires' disease.

  van Loenhout JAF, et al

  2014

  Journal of Infection 68(6): 527-533
• Serological and virological investigation of the role of the herpesviruses EBV, CMV, HHV-6 in post-infective fatigue syndrome.

  Cameron B, et al

  2010

  Journal of Medical Virology 82(10): 1684-1688.
• Serological and virological investigation of the role of the herpesviruses EBV, CMV, HHV-6 in post-infective fatigue syndrome.

  Cameron B et al

  2010

  Journal of Medical Virology 82(10): 1684-1688.
• Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.

  Loebel M, et al

  2017

  PLoS One 12 (6): e0179124.
• Serum BAFF and APRIL levels, T lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy/chronic fatigue syndrome.

  Lunde S et al

  2016

  PLoS ONE 11(8): e0161226. Doi: 10.1371/journal.pone.0161226.
• Serum GDF-15 Levels Accurately Differentiate Patients with Primary Mitochondrial Myopathy, Manifesting with Exercise Intolerance and Fatigue, from Patients with Chronic Fatigue Syndrome

  Bermejo-Guerrero L

  2023

  Journal of Clinical Medicine
• Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In Vitro.

  Flaskamp L, et al

  2022

  Cells 11 (15): 2376.
• Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes.

  Kerr JR, et al

  2008

  Journal of Clinical Pathology 61(6): 730-739.
• Sex Differences in Hemodynamic Response to Exercise in Patients With Myalgic Encephalomyelitis: Insights From Invasive Cardiopulmonary Exercise Testing

  Wichmann Madsen K et al

  2023

  American Journal of Respiratory and Critical Care Medicine
• Sex differences in post-exercise fatigue and function in myalgic encephalomyelitis/chronic fatigue syndrome

  Friedberg F

  2023

  Scientific Reports
• Sex differences in post-exercise fatigue and function in myalgic encephalomyelitis/chronic fatigue syndrome.

  Friedberg F, et al

  2023

  Scientific Reports 13: 5442.
• Sex Differences in the Correlation between Fatigue Perception and Regional Gray Matter Volume in Healthy Adults: A Large-Scale Study.

  Putra HA et al

  2022

  Journal of Clinical Medicine 11 (20): 6037.
• Sex Differences in the Correlation between Fatigue Perception and Regional Gray Matter Volume in Healthy Adults: A Large-Scale Study.

  Putra HA et al

  2022

  Journal of Clinical Medicine 11 (20): 6037.
• Sex-Dependent Transcriptional Changes in Response to Stress in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Project

  Gamer J et al

  2023

  International journal of Molecular Sciences
• Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.

  Nikiliza A et al

  2021

  Journal of Translational Medicine 19 (1): 370.
• Shared microglial mechanisms underpinning depression and chronic fatigue syndrome and their comorbidities.

  Filho AJ et al

  2019

  Behaviour and Brain Research [Epub ahead of print]
• Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Bragee B et al

  2020

  Frontiers in Neurology 11.
• Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population.

  Khoo T, Proudman S and Limaye V

  2019

  Clinical Rheumatology 38 (5): 1271-1276.
• Similar Patterns of Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue and Post-COVID-19 Syndromes

  Ryabkova VA, et al.

  2024

  Pathophysiology 31 (1): 1-17
• Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation

  Vu LT, et al.

  2024

  Cell reports, Medicine 5 (1): 101373
• Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. B

  Sato W et al

  2021

  rain, Behaviour & Immunology 95: 245-255.
• Skewing of the B cell receptor repertoire in myalgic encephalomyelitis/chronic fatigue syndrome. Brain,

  Sato W, et al

  2021

  Behaviour & Immunology 95: 245-255.
• Skin Temperature Circadian Rhythms and Dysautonomia in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Role of Endothelin-1 in the Vascular Tone Dysregulation

  Cambras T et al

  2023

  International journal of molecular sciences
• Sleep abnormalities in chronic fatigue syndrome/ myalgic encephalomyelitis: a review.

  Jackson ML and Bruck D

  2012

  Journal of Clinical Sleep Medicine 8(6): 719-728.
• Sleep Disorders and Chronic Pain Syndromes in the Pediatric Population

  Oh A et al

  2023

  Seminars in Pediatric Neurology
• Sleep disorders in patients with a neurocognitive disorder.

  Moderie C et al

  2021

  Encephale : S0013-7006 (21) 00229-3. [Article in French] [Epub ahead of print.]
• Sleep patterns among patients with chronic fatigue: A polysomnography-based study.

  Pajediene E et al

  2018

  The Clinical Respiratory Journal 12 (4): 1389-1397
• Sleep Quality in Adolescents with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).

  Josev EK et al

  2017

  Journal of Clinical Sleep Medicine 13 (9): 1057-1066.
• Sleep-wake behaviour in chronic fatigue syndrome.

  Rahman K et al

  2011

  Sleep 34(5): 671-678.
• Sleep-wake rhythm disturbances and perceived sleep in adolescent chronic fatigue syndrome.

  Pedersen M et al

  2017

  Journal of Sleep Research 26 (5): 595-601.
• Sleeping and Dietary Factors Associated with Chronic Fatigue Syndrome in Taiwanese Preschoolers

  Huang S-F and Duan H-Y

  2023

  Children 10 (7): 1149
• Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study.

  Scott LV et al

  1999

  Psychoneuroendocrinology 24(7): 759-768.
• Small Heart with Low Cardiac Output for Orthostatic Intolerance in Patients With Chronic Fatigue Syndrome.

  Miwa K and Fujita M

  2011

  Clinical Cardiology 34(12): 782-786.
• SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.

  Schwartz RB et al

  1994

  American Journal of Roentgenology 162(4).
• Spinal Fluid Abnormalities in Patients with Chronic Fatigue Syndrome.

  Natelson BH et al

  2005

  Clinical and Vaccine Immunology 12(1): 52-55.
• Static and dynamic functional connectivity in patients with chronic fatigue syndrome: use of arterial spin labelling fMRI.

  Boissoneault J et al

  2018

  Clinical Physiology and Functional Imaging 38 (10): 128-137.
• Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal Disrupted Immune Signatures.

  Van Booven DJ et al

  2023

  International Journal of Molecular Sciences 24(3): 2698.
• Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal Disrupted Immune Signatures.

  Van Booven DJ et al

  2023

  International Journal of Molecular Sciences 24(3): 2698.
• Structural brain changes versus self-report: machine-learning classification of chronic fatigue syndrome patients.

  Sevel LS et al

  2018

  Experimental Brain Research [Epub ahead of print]
• Study on Sports, Extracurricular Activities, Electronic Device Usage Factors Associated with Chronic Fatigue Syndrome in Taiwanese Preschoolers

  Huang S and Duan H

  2023

  Children
• Study on the Relationship between the miRNA-centered ceRNA Regulatory Network and Fatigue.

  Yang X, et al

  2021

  Journal of Molecular Neuroscience [Epub ahead of print].
• Studying College Students for the Development of Infectious Mononucleosis and ME/CFS.

  Feder HM and Wormser GP.

  2021

  Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America 73(11):e3747.
• Subclassifying Chronic Fatigue Syndrome through Exercise Testing.

  VanNess JM et al

  2003

  Medicine & Science in Sports & Exercise 35(6): 908-913.
• Subclassifying Chronic Fatigue Syndrome through Exercise Testing.

  Van Ness JM, et al

  2003

  Medicine & Science in Sports & Exercise 35(6): 908-913.
• Subcortical and Default Mode Network connectivity is impaired in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Inderyas M, et al.

  2024

  Frontiers in Neuroscience: 17
• Subcortical brain segment volumes in Gulf War Illness and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Addiego FL et al. (2021) et al

  2021

  Life Sciences 282: 119749.
• Subjective and objective cognitive function in adolescent with chronic fatigue following Epstein-Barr virus infection.

  Øie MG, et al

  2022

  Journal of Psychosomatic Research 163:111063.
• Subjective and objective cognitive function in adolescent with chronic fatigue following Epstein-Barr virus infection.

  Oie MG et al

  2022

  Journal of Psychosomatic Research 163:111063.
• Submaximal Exercise Provokes Increased Activation of the Anterior Default Mode Network During the Resting State as a Biomarker of Postexertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Rayhan RU and Baraniuk JN

  2021

  Frontiers in Neuroscience 15: 748426.
• Submaximal Exercise Provokes Increased Activation of the Anterior Default Mode Network During the Resting State as a Biomarker of Postexertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Rayhan RU and Baraniuk JN

  2021

  Frontiers in Neuroscience 15: 748426.
• Substrate utilisation of cultured skeletal muscle cells in patients with CFS.

  Tomas C, et al

  2020

  Science Reports
• Subtyping Patients with Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) By Course of Illness.

  Stoothoff J et al

  2017

  Journal of Biosensors, Biomarkers and Diagnoses 2 (1).
• Successful Intravenous Immunoglobulin Therapy in 3 Cases of Parvovirus B19-Associated Chronic Fatigue Syndrome.

  Kerr JR, et al

  2003

  Clinical Infectious Diseases 36(9): e100-e106.
• Suggested Pathology of Systemic Exertion Intolerance Disease: Impairment of the E3 Subunit or Crossover of Swinging Arms of the E2 Subunit of the Pyruvate Dehydrogenase Complex Decreases Regeneration of Cofactor Dihydrolipoic Acid of the E2 Subunit.

  Bohne V and Bohne O

  2019

  Medical Hypothesis [Epub ahead of print]
• Suppressed immune and metabolic responses to intestinal damage-associated microbial translocation in myalgic encephalomyelitis/chronic fatigue syndrome

  Uhde M et al

  2023

  Brain, Behavior, & Immunity – Health
• Survey of Anti-Pathogen Antibody Levels in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  O'Neal AJ et al

  2022

  Proteomes 10 (2): 21.
• Survey of Anti-Pathogen Antibody Levels in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  O'Neal AJ, et al

  2022

  Proteomes 10 : 21.
• Surveying the Metabolic and Dysfunctional Profiles of T Cells and NK Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Maya J

  2023

  International Journal of Molecular Sciences 24 (15): 11937
• Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort.

  Vaes AW, et al

  2023

  Journal of Translational Medicine 21: 112.
• Symptoms of autonomic dysfunction in chronic fatigue syndrome.

  Newton JL et al

  2007

  QJM 100(8): 519-526.
• Synbiotic Supplementation Improves Quality of Life and Inmunoneuroendocrine Response in Patients with Fibromyalgia: Influence of Codiagnosis with Chronic Fatigue Syndrome

  Hinchado M

  2023

  Nutrients
• Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

  Aoun Sebaiti M et al

  2022

  Scientific Reports 12 (1): 2157.
• Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)

  Do-Young K, et al

  2020

  Journal of Translational Medicine 18: 7.
• Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Maksoud R, et al

  2021

  Healthcare 9: 568.
• Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.

  Estevez-Lopez F, et al

  2020

  Journal of Clinical Medicine 9 (5).
• Systemic antibody responses against gut microbiota flagellins implicate shared and divergent immune reactivity in Crohn's Disease and chronic fatigue syndrome

  Bourgonje AR, et al.

  2024

  Journal of Crohn's and Colitis 18 (1): i122
• Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients.

  Vogl T, et al

  2022

  Science Advances 8 (38): eabq2422.
• Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients.

  Vogl T et al

  2022

  Science Advances 8 (38): eabq2422.
• Systemic exertion intolerance disease associated to neuroendocrine dysfunction and cortical atrophy: a case report.

  López-Amador N

  2022

  Family Practice : cmac060 [Epub ahead of print].
• Systemic exertion intolerance disease/chronic fatigue syndrome is common in sleep centre patients with hypersomnolence: A retrospective pilot study.

  Maness C et al

  2018

  Journal of Sleep Research 28 (3).
• Systemic Hyperalgesia in Females with Gulf War Illness, Chronic Fatigue Syndrome and Fibromyalgia.

  Surian A and Baraniuk A

  2020

  Scientific Reports 10: 5751.
• Tai Chi increases functional connectivity and decreases chronic fatigue syndrome: A pilot intervention study with machine learning and fMRI analysis.

  Wu K, et al

  2022

  PLoS One 17 (12): e0278415.
• Task Related Cerebral Blood Flow Changes of Patients with Chronic Fatigue Syndrome: An Arterial Spin Labeling Study

  Staud R et al

  2018

  Fatigue 6 (2): 63-79.
• Tenuous between chronic fatigue syndrome and pyruvate dehydrogenase deficiency. (Article in Norwegian)

  Bliksrud YT.

  2017

  Tidsskr Nor Laegeforen 137 (23-24).
• The Abnormal Cardiac Index and Stroke Volume Index Changes During a Normal Tilt Table Test in ME/CFS Patients Compared to Healthy Volunteers, are Not Related to Deconditioning,

  Campen CM and Visser FC

  2018

  Journal of Thrombosis and Circulation 107.
• The Association between Daytime Napping and Cognitive Functioning in Chronic Fatigue Syndrome.

  Gotts ZM et al

  2015

  PLoS ONE 10(1): e0117136.
• The chronic fatigue syndrome is a disease of the autonomic nervous system. Sometimes.

  Freeman R

  2002

  Clinical Autonomic Research 12(4): 231-233.
• The clinical value of cytokines in chronic fatigue syndrome.

  Yang T et al

  2019

  Journal of Translational Medicine 17 (1): 213.
• The Common Immunogenic Etiology of Chronic Fatigue Syndrome: From Infections to Vaccines via Adjuvants to the ASIA Syndrome.

  Rosenblum H et al

  2011

  Infectious Disease Clinics of North America 25(4): 851-863.
• The Concept of ‘Illness Without Disease' Impedes Understanding of Chronic Fatigue Syndrome: A Response to Sharpe and Greco.

  Lubet S and Tuller D

  2020

  Medical Humanities [Epub ahead of print].
• The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE).

  Pheby D, et al

  2020

  Healthcare 8 (2).
• The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome,

  Jason LA et al

  2018

  Journal of Health Psychology 26 (2): 238-248.
• The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP 2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Eaton-Fitch N et al

  2021

  Journal of Translational Medicine 19 (1): 306.
• The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function.

  Tomas C et al

  2020

  PLoS One 15 (4).
• The Effects of Symptomatic and Intervention-Specific Heterogeneity on Outcomes for Patients with Chronic Fatigue Syndrome

  May M

  2023

  University of Miami
• The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications.

  Varesi A, et al

  2021

  Journal of Clinical Medicine 10 (21): 5077.
• The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

  O'Neal AJ and Hanson MR

  2021

  Frontiers in Medicine (Lausanne) 8: 688486.
• The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes.

  de Vega WC and McGowan PO.

  2017

  Epigenomics 9 (11): 1337-1340.
• The etiologic relation between disequilibrium and orthostatic intolerance in patients with myalgic encephalomyelitis (chronic fatigue syndrome).

  Miwa K and Inoue Y.

  2018

  Journal of Cardiology [Epub ahead of print]
• The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE.

  Scheibenbogen C, et al

  2017

  Journal of Translational Medicine 15: 162.
• The experience of sleep in chronic fatigue syndrome: A qualitative interview study with patients.

  Gotts ZM et al

  2016

  British Journal of Health Psychology 21(1): 71-92.

  Funded by the ME Association
• The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.

  Yang CA, et al

  2018

  Journal of Translational Medicine 16 (1): 231.
• The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

  König RS, et al

  2022

  Frontiers in Immunology 12: 628741.
• The higher resting heart rate in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients compared to healthy controls: relation with stroke volumes.

  van Campen CM and Visser FC

  2022

  Medical Research Archives 10 (6).
• The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS.

  Kashi A et al

  2019

  Diagnostics 9 (3): 82.
• The Impact of a 4-Hour Sleep Delay on Slow Wave Activity in Twins Discordant for Chronic Fatigue Syndrome.

  Armitage R et al

  2007

  Sleep 30(5): 657-662
• The impact of atopic disease on the risk of post-infectious fatigue and irritable bowel syndrome 3 years after Giardia infection. A historic cohort study.

  Hunskar GS, et al

  2012

  Scandinavian Journal of Gastroenterology 47(8-9): 956-961.
• The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID

  Grabowska A et al

  2023

  Frontiers in Public Health
• The importance of estimating prevalence of ME/CFS in future epidemiological studies of long COVID

  Grabowska A et al

  2023

  Research Gate
• The Link Between Empty Sella Syndrome, Fibromyalgia, and Chronic Fatigue Syndrome: The Role of Increased Cerebrospinal Fluid Pressure.

  Hulens M et al

  2023

  Journal of Pain Research 16: 205-219.
• The Link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology.

  Hulens M et al

  2018

  Journal of Pain Research 11: 3129-3140
• The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

  Murga I, et al

  2021

  Journal of Translational Medicine 19 (1): 494.
• The maintained attention assessment in patients affected by Myalgic encephalomyelitis/chronic fatigue syndrome: a reliable biomarker?

  Murga I et al

  2021

  Journal of Translational Medicine 19 (1): 494.
• The Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with Joint Hypermobility Show Larger Cerebral Blood Flow Reductions during Orthostatic Stress Testing Than Patients without Hypermobility: A Case Control Study.

  Van Campen C, et al

  2021

  Medical Research Archives, [S.l.], v. 9, n. 6, june 2021.
• The nosology of sub-acute and chronic fatigue syndromes that follow infectious mononucleosis.

  White PD, et al

  2004

  Psychological Medicine 34(3): 499: 507.
• The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Nunes M, et al

  2022

  Pharmaceuticals 15 : 931.
• The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Nunes M et al

  2022

  ResearchSquare [Preprint].
• The occurrence of hyperactivated platelets and fibrinaloid microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Nunes M, et al

  2022

  ResearchSquare [Preprint].
• The ocular signs and symptoms of chronic fatigue syndrome.

  Caffery BE et al

  1994

  Journal of The American Optometric Association 65 (3): 187-91.
• The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

  Renz-Polster H et al

  2022

  Frontiers in Cellular Neuroscience 16: 888232.
• The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

  Renz-Polster H et al

  2022

  Frontiers in Cellular Neuroscience 16: 888232.
• The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

  Renz-Polster H et al

  2022

  Frontiers in Cellular Neuroscience 16: 888232.
• The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

  Renz-Polster H et al

  2022

  Frontiers in Cellular Neuroscience 16: 888232.
• The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure.

  Renz-Polster H et al

  2022

  Frontiers in Cellular Neuroscience 16: 888232.
• The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome.

  Rasa-Dzelzkaleja S, et al

  2023

  Journal of Translational Medicine 21: 33.
• The persistent viral infections in the development and severity of myalgic encephalomyelitis/chronic fatigue syndrome.

  Rasa-Dzelzkaleja S et al

  2023

  Journal of Translational Medicine 21: 33.
• The Potential Role of Hypothalamic Phospholipid Liposomes in the Supportive Therapy of Some Manifestations of Post-COVID-19 Condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Brain Fog

  Menichetti F

  2023

  Journal of clinical medicine
• The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

  Kell DB and Pretorius E

  2022

  The Biochemical Journal 479 (16): 1653-1708.
• The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

  Kell DB and Pretorius E

  2022

  The Biochemical Journal 479 (16): 1653-1708.
• The Potential Role of Ocular and Otolaryngological Mucus Proteins in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome

  Huitsing K et al

  2023

  Research Square
• The potential role of ocular and otolaryngological mucus proteins in myalgic encephalomyelitis/chronic fatigue syndrome

  Huitsing K, et al.

  2024

  Molecular Medicine 30 (1): 1
• The presence of overlapping quality of life symptoms in primary antibody deficiency (PAD) and chronic fatigue syndrome (CFS).

  Bansal RA et al

  2020

  Allergy, Asthma & Clinical Immunology 16 (21).
• The putative glymphatic signature of chronic fatigue syndrome: A new view on the disease pathogenesis and therapy.

  Wostyn P and De Deyn P.

  2018

  Medical Hypotheses 118: 142-145.
• The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis,

  Morris G et al

  2018

  Sleep Medicine Reviews 41: 255-265.
• The relation of sleep difficulties to fatigue, mood and disability in chronic fatigue syndrome.

  Morriss RK et al

  1997

  Journal of Psychosomatic Research 42(6): 597-605.
• The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.

  Oosterwijck JV et al

  2017

  Pain Physicians 20(3): E389-E399.

  Funded by the ME Association
• The Role of Cytokines in Muscle Fatigue in Patients with Chronic Fatigue Syndrome (CFS)

  Anne McArdle et al

  2007

  The Faseb Journal

  Funded by the ME Association
• The role of enterovirus in chronic fatigue syndrome.

  Chia JK

  2005

  Journal of Clinical Pathology 58 (11): 1126 - 1132.
• The Role of Immunity and Inflammation in ME/ CFS and Post-COVID Syndrome: Implications for Treatment.

  Comhaire F

  2022

  MedLife Clinics Volume 4 (2): 1043.
• The Role of Immunity and Inflammation in ME/ CFS and Post-COVID Syndrome: Implications for Treatment.

  Comhaire F

  2022

  MedLife Clinics Volume 4 (2): 1043.
• The Role of Kynurenine Pathway and NAD Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Dehhaghi M, et al

  2022

  Aging and disease 13 (3): 698-711.
• The Role of Kynurenine Pathway and NAD Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Dehhaghi M et al

  2022

  Aging and disease 13 (3): 698-711.
• The Role of Leptin and Inflammatory Related Biomarkers in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Assil RA and Younger JW

  2022

  Proceedings from 16th Annual Cardiometabolic Health Congress in National Harbor, USA , 14-17 October 2021 80 (1): 6.
• The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) – associations with symptoms.

  Jonsjo MA et al

  2020

  Psychoneuroendocrinology 113.
• The role of mitochondria in ME/CFS: a perspective.

  Tomas C and Elson JL

  2019

  Fatigue: Biomedicine, Health & Behaviour.
• The role of psychiatry in diagnosis and treatment of paediatric chronic fatigue syndrome – a scoping literature review 

  Dolp R et al

  2023

  International journal of adolescent medicine and health
• The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Grande T et al

  2023

  Medicina
• The Role of Psychotherapy in the Care of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

  Grande T et al

  2023

  Medicina
• The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput genetic, epigenetic, and gene expression studies.

  Malato J, et al

  2021

  medRxiv [Preprint]2021.03.23.21254175.
• The significance of oxidative stress in the pathophysiology of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

  Walker MOM, et al

  2022

  Medical Research Archives 10 (9).
• The symptoms of chronic fatigue syndrome are related to abnormal ion channel function.

  Chaudhuri A et al

  2000

  Medical Hypotheses 54(1): 59-63.
• The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis.

  Lacerda EM, et al

  2017

  Open Journal of Bioresources 4: 4.
• The UK ME/CFS Biobank: a disease-specific biobank for advancing clinical research into myalgic encephalomyelitis/chronic fatigue syndrome,

  Lacerda EM, et al

  2018

  Frontiers in Neurology 9: 1026.
• The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.

  Thomas N et al

  2022

  Frontiers in Neuroendocrinology: 100995 66: 100995.
• The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.

  Thomas N et al

  2022

  Frontiers in Neuroendocrinology 66: 100995.
• The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.

  Thomas N et al

  2022

  Frontiers in Neuroendocrinology: 100995. [Epub ahead of print]
• The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.

  Thomas N, et al

  2022

  Frontiers in Neuroendocrinology: 100995. [Epub ahead of print]
• The use of oxygen as a possible screening biomarker for the diagnosis of chronic fatigue.

  Pifarré F, et al

  2022

  Apunts Sports Medicine 57 (214): 100379.
• The variation of the 5-hydroxytryptamine system between chronic unpredictable mild stress rats and chronic fatigue syndrome rats induced by forced treadmill running.

  Cao Y and Li Q.

  2017

  Neuroreports 28 (11): 630-637.
• The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome
• Therapeutic Potential of Indian Medicinal Herbs and Current Therapeutic Approach used to Mitigate the Symptoms of Chronic Fatigue Syndrome: A Review

  Sigh N et al

  2023

  Current Traditional Medicine
• Tissue specific signature of HHV-6 infection in ME/CFS.

  Kasimir F, et al

  2022

  Frontiers in Molecular Biosciences 9: 1044964.
• Tissue specific signature of HHV-6 infection in ME/CFS.

  Kasimir F, et al

  2022

  Frontiers in Molecular Biosciences 9: 1044964.
• Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study.

  Sc et al

  2021

  Journal of Clinical Medicine 10 (11): 2420.
• Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID

  Tate W et al

  2023

  International journal of molecular science
• Transforming growth factor beta (TGF-β) in adolescent chronic fatigue syndrome.

  Wyller VB et al

  2017

  Journal of Translational Medicine 15: 245.
• Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Balinas C et al

  2019

  Journal of Translational Medicine 17 (401).
• Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Sasso EM et al

  2022

  Molecular Medicine 28: 98.
• Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.

  Sasso EM et al

  2022

  Molecular Medicine 28: 98.
• Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

  Al-Hakeim H et al

  2023

  Frontiers in Molecular Neuroscience
• Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Simonato M, et al

  2021

  Biomedicines 9 : 1724.
• Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Simonato M et al

  2021

  Biomedicines 9 : 1724.
• Turning a Corner in ME/CFS Research.

  Pheby DFH , et al

  2021

  Medicina 57: 1012.
• Two symptoms can accurately identify post-exertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome

  Davenport T et al

  2023

  Work
• Two-Day Cardiopulmonary Exercise Testing in Females with a Severe Grade of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison with Patients with Mild and Moderate Disease.

  van Campen CL, et al

  2020

  Healthcare 8 (3): 192.
• Two-month period of 500 mg lecithin-based delivery form of quercetin daily dietary supplementation counterbalances chronic fatigue symptoms: A double-blind placebo controlled clinical trial

  Rondanelli M et al

  2023

  Biomedicine & Pharmacotherapy
• Typing myalgic encephalomyelitis by infection at onset: A DecodeME study

  Bretherick A et al

  2023

  NIHR Open Research
• Understanding muscle dysfunction in chronic fatigue syndrome.

  Rutherford G et al

  2016

  Journal of Ageing Research doi: 10.1155/2016/2497348.
• Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and the Emerging Osteopathic Approach: A Narrative Review.

  Larrimore C, et al

  2019

  Journal of American Osteopathic Association 119 (7): 446-455.
• Understanding neuromuscular disorders in chronic fatigue syndrome. F

  Jammes Y and Retornaz F

  2019

  1000Research [Epub ahead of print].
• Understanding the Experience and Impacts of Brain Fog in Chronic Pain: A Scoping Review

  Dass R et al

  2022

  Canadian Journal of Pain 7:1
• Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité fatigue center

  Steiner S et al

  2023

  Autoimmunity Reviews
• Unexplained exertional intolerance associated with impaired systemic oxygen extraction.

  Melamed K, et al

  2019

  European Journal of Applied Physiology 119 (10): 2375-2389.
• Unexplained post-acute infection syndromes.

  Choutka J, et al

  2022

  Nature Medicine 28 (5): 911-923.
• Unexplained post-acute infection syndromes.

  Choutka J, et al

  2022

  Nature Medicine 28 (5): 911-923.
• Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

  Theorell J et al

  2017

  Frontiers in Immunology 8: 723.
• Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFS.

  Cheema AK, et al

  2020

  Journal of Cellular and Molecular Medicine [Epub ahead of print].
• Unsupervised cluster analysis reveals distinct subtypes of ME/CFS patients based on peak oxygen consumption and SF-36 scores

  Lacasa M et al

  2023

  Clinical Therapeutics 45 (12): 1228–1235
• Urine Metabolomics Exposes Anomalous Recovery after Maximal Exertion in Female ME/CFS Patients.

  Glass KA, et al

  2023

  International Journal of Molecular Sciences 24 (4): 3685.
• Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

  Shimosako N and Kerr JR

  2014

  Journal of Clinical Pathology 67(12): 1078-1083.
• Use of valganciclovir in patients with elevated antibody titers against Human Herpesvirus-6 (HHV-6) and Epstein-Barr Virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue.

  Kogelnik AM et al

  2006

  Journal of Clinical Virology 37(Supplement 1): S33-S38.
• Using Plasma Autoantibodies of Central Nervous System Proteins to Distinguish Veterans with Gulf War Illness from Healthy and Symptomatic Controls.

  Abou-Donia M et al

  2020

  Brain Sciences 10 (9).
• Using structural and functional MRI as a neuroimaging technique to investigate chronic fatigue syndrome/myalgic encephalopathy: a systematic review

  Almutairi B et al

  2020

  BMJ Open 10 (8).
• Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID

  Yamamoto Y et al

  2023

  Journal of clinical medicine
• Utility of the Blood for Gene Expression Profiling and Biomarker Discovery in Chronic Fatigue Syndrome.

  Vernon SD, et al

  2002

  Disease Markers 18(4): 193-199.
• Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.

  Cabanas H et al

  2019

  Molecular Medicine 25 (1): 14.
• Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.

  Cabanas H et al

  2019

  Molecular Medicine 25 (1): 14.
• Validation of the Bath CRPS Body Perception Disturbance Scale.

  Brink AFT et al

  2021

  Journal of pain 22 (11): 1371-1384.
• Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

  Moneghetti KJ et al

  2018

  Scientific Reports 8 (1): 2779.
• Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalized anxiety disorder: an in vivo 3.0 T 1H MRS imaging study.

  Mathew SJ et al

  2009

  NMR in Biomedicine 22(3): 251-258.
• Viruses belonging to Anelloviridae or Circoviridae as a possible cause of chronic fatigue.

  Grinde B

  2021

  Journal of Translational Medicine18 (1): 485.
• Viruses Can Cause Disease in the Absence of Morphological Evidence of Cell Injury: Implication for Uncovering New Diseases in the Future.

  Oldstone MBA

  1989

  Journal of Infectious Diseases 159(3): 384-389.
• Vision-related symptoms as a clinical feature of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis? Evidence from the DePaul Symptom Questionnaire.

  Hutchinson CV et al

  2014

  British Journal of Ophthalmology , 98 , 144-145.
• Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME).

  Wilson RL et al

  2018

  Frontiers in Psychology 9: 1468.
• Volumetric differences in hippocampal subfields and associations with clinical measures in myalgic encephalomyelitis/chronic fatigue syndrome.

  Thapalia K et al

  2022

  Journal of Neuroscience Research 100 (7): 1476-1486.
• What Causes ME/CFS: The Role of the Dysfunctional Immune System and Viral Infections.

  Bansal RA et al. et al

  2022

  Journal of Immunology and Allergy 3(2): 1-15.
• What Causes ME/CFS: The Role of the Dysfunctional Immune System and Viral Infections.

  Bansal RA et al

  2022

  Journal of Immunology and Allergy 3(2): 1-15.
• What Causes Prolonged Fatigue after Infectious Mononucleosis-and Does It Tell Us Anything about Chronic Fatigue Syndrome?

  White PD, et al

  2007

  Journal of Infectious Diseases 196(1): 4-5.
• What do lumbar puncture and jugular venoplasty say about a connection between chronic fatigue syndrome and idiopathic intracranial hypertension?

  Higgins N et al

  2014

  EJMINT : 1448000223
• What happens to muscles in fibromyalgia syndrome

  Umay E et al

  2020

  International Journal of Medical Science 189 (2): 749-756.
• What lies beneath: White matter microstructure in pediatric myalgic encephalomyelitis/chronic fatigue syndrome using diffusion MRI

  Josev E et al

  2023

  Journal of neuroscience research
• Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival.

  Nguyen CB et al

  2017

  Journal Translational Medicine 15:102.
• Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

  Bouquet J, et al

  2019

  PLoS One 14 (3).
• Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

  Bouquet J, et al

  2019

  PLoS One 14 (3).
• Whole blood human transcriptome and virome analysis of ME/CFS patients experiencing post-exertional malaise following cardiopulmonary exercise testing.

  Bouquet J et al

  2019

  PLoS One 14 (3).
• Whole-body cryotherapy as a treatment for chronic medical conditions?

  Tabisz H et al

  2023

  British Medical Bulletin
• Worsening Symptoms Is Associated with Larger Cerebral Blood Flow Abnormalities during Tilt-Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  Van Campen L et al

  2023

  Medicina
• XMRV and CFS – the sad end of a story.

  van Kuppeveld FJM and van der Meer JWM.

  2012

  The Lancet 379(9814): e27-e28.
• XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.

  Panelli S, et al

  2017

  Frontiers in Public Health 5: 108.
• XMRV controversy laid to rest.

  Holmes D

  2012

  The Lancet Infectious Diseases 12(11): 834.
• Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial

  Lacasa M et al

  2023

  Nutrients
•  A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients 

  Cheng Y et al

  2023

  Gene